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Abstract
Intrauterine growth restriction (IUGR) is a pregnancy condition where fetal growth is
suboptimal, resulting in an infant born small for gestational age (<10th percentile) and is
associated with metabolic disorders such as type 2 diabetes in adulthood. This study aims to
understand tissue-specific adaptations to fetal undernutrition which predispose the individual
to metabolic disorders in adulthood. A model of growth restriction in mice was established
using 70% of maternal ad libitum total food (g) (E6.5-birth). At weaning, male offspring
received standard chow or a HFHS diet. Body weight and random blood glucose levels were
measured at 6 months. To assess metabolism at 6 or 7 months, glucose tolerance, pyruvate
challenge and hepatic portal vein insulin challenge tests were administered and serum peptide
markers for obesity and diabetes were measured. Metabolic cages were also used at 2 and 7
months to measure activity, food intake and respiratory exchange ratios (RERs). Adult liver,
adipose and skeletal muscle and fetal liver was collected for RNA sequencing. Maternal
nutrient restricted (MNR) offspring were growth restricted with disproportionately smaller
fetal livers. 19% of standard chow-fed MNR offspring became glucose intolerant. On an
isocaloric high-fat high-sugar diet no differences in MNR growth or glucose metabolism
were detected. However, RERs were reduced at all timepoints in MNR on a HFHS relative to
MNR on standard chow. Differences in transcription of genes involved in hypoxia signalling
were detected and HIF-2a and HIF-3a proteins were increased in fetal liver of MNR
offspring. Genes differentially expressed in the fetus were not differentially expressed at 6
months. Gene expression of metabolically regulatory transcripts in liver, adipose and skeletal
muscle did not differ in all MNR and glucose intolerant MNR relative to controls. This
model results in a susceptible and non-susceptible population of maternal nutrient restricted
offspring and supports the concept of hypoxia signalling contributing to fetal adaptations.
Understanding adaptations in hepatic hypoxia signalling in response to fetal undernutrition
and how they vary in susceptible and unsusceptible populations will provide insight into how
fetal nutrition can influence adult metabolism.

Keywords
growth restriction , glucose tolerance, gene expression, hypoxia, HIF-2a, maternal nutrient
restriction.
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Chapter 1 : Introduction
Intrauterine Growth Restriction
Clinically intrauterine growth restriction (IUGR) or fetal growth restriction (FGR) is a
pregnancy condition where the fetal growth rate is reduced, and the infant is born small
for gestational age (<10th percentile). Causes can be maternal, fetal or placental. Maternal
causes include smoking, infections and malnutrition (1). Alternatively, restriction to fetal
growth can be caused by chromosomal abnormalities in the fetus or insufficient
development of the placenta (1). Maternal malnutrition and placental insufficiency are the
most common causes in developing and developed nations, respectively (2). IUGR can
also be classified into early and late onset. Early-onset IUGR often results in a reduction
in all organs proportional to body weight and is termed symmetric growth restriction (1).
Conversely, late-onset IUGR can result in asymmetric growth restriction with
preservation in brain and heart size at the expense of reductions of less essential organs
such as the lungs, liver, and kidneys (1). Infants born from pregnancies complicated with
IUGR are at increased risk for perinatal complications (3) and as adults are more likely to
develop obesity, glucose intolerance and type II diabetes (4,5).

Developmental Origins of Health and Disease
Studies of populations that were exposed to the Dutch Famine in utero found increased
occurrence of glucose intolerance and cardiovascular disease (6,7). Since these pivotal
studies many other studies have demonstrated that pathological reduction in fetal growth
can influence adult health. Such studies have led to the concept of ‘Developmental
Origins of Health and Disease’ (DOHaD). In this concept, adversity during fetal
development and early life can result in adaptations enhancing fetal survival. However,
these adaptations may not be beneficial to the individual postnatally. For instance, fetal
nutrient restriction may prime that individual to more efficiently store nutrients. If the
infant is born into a nutrient-rich environment such as western society, fetal adaptations
may increase their risk for metabolic disorders. This hypothesis is termed the ‘Thrifty
Phenotype Hypothesis’(8).
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Models of Growth Restriction
Studies investigating the “Thrifty Phenotype Hypothesis” in human IUGR populations
are complicated by many confounding variables and ethical limitations. Some of these
variables can be controlled or adjusted for in the study design or analysis; including
ethnicity, substance use and socioeconomic status. However, estimating length, extent
and onset of fetal nutrient restriction can be more challenging. Additionally, adaptations
are likely tissue-specific and obtaining fetal and adult samples of metabolically important
tissues may not be feasible. Due to these challenges, animal models have been developed
to understand mechanisms underlying IUGR and DOHaD.
To date, many animal models have been used with different species. Studies in larger
mammals like pigs are informative due to similarities to humans in physiology,
morphology and diet (9). However, relatively long lifespans limit outcomes studied to
early life rather than adulthood. Additionally, these models are costly and will be
challenging for genetic manipulation to prove the mechanistic importance of altered
genes. Rodents such as mice are valuable in providing cost-efficient long-term studies,
with similar genetics and metabolism to humans and the potential for downstream genetic
manipulation.
IUGR models in rodents induce growth restriction by various strategies including
intrauterine artery ligation, hypoxia, lipopolysaccharide (LPS) exposure and maternal
nutrient restriction. Artery ligation results in decreased nutrient and oxygen delivery to
the fetus and provides a model of placental insufficiency. However, it is limited to lategestation surgeries and results in a higher fetal mortality than controls exposed to sham
surgeries (10). Recently, a genetic knock out of a transcription factor important in
trophoblast differentiation, AP-2y, has also been used to model placental insufficiency
(11). Maternal exposure to low oxygen chambers results in reduced oxygen delivery to
the pups similar to a pregnancy at high altitude and LPS-induced growth restriction can
model IUGR from infections (12,13). Such models can be early to late onset and model a
specific maternal condition. Maternal nutrient restriction (MNR) also allows a flexible
onset with some models beginning nutrient restriction prior to conception and others in
early to late gestation (14–16). Additionally, total calories, or specific micro or macro
nutrients such as iron or protein can be restricted (15–17). Variations in maternal
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nutrition can model maternal nutritional challenges experienced in humans such as iron
deficiencies, inadequate access to protein, or total calorie malnourishment. Additionally,
total calorie maternal nutrient restriction can be used to model the reduced nutrient
delivery to the fetus in placental insufficiency. Each type of model is applicable to
maternal conditions experienced in human pregnancies and are useful to understanding
how certain adversities affect fetal and long-term health.

Fetal Adaptations to Growth Restriction
Growth restriction models exhibit reduced fetal and birth weight. Reductions in growth
are symmetric or asymmetric depending on the type and time of insult (18–20). Growth
restriction has also been associated with hypoglycemia, hypoinsulinemia and increased
insulin sensitivity in the fetus or young offspring, suggesting an immediate impact on
fetal glucose metabolism (15,21,22).
In humans and animal models, reduction in liver size relative to body weight or fractional
growth rates suggests that the liver is sensitive to fetal nutrition (19,20,23). Reduced liver
size from maternal nutrient restriction or maternal hypoxia is associated with reduced
fetal glycogen deposits (24,25) and decreased hepatocyte numbers (26). Increased
expression of genes in fatty acid oxidation, gluconeogenesis and insulin signalling in
MNR fetal liver accompany phenotypic changes (27,28). Evidence of increased
glucocorticoid signalling has also been detected but appears to be specific to the male
fetus (29).
In addition to liver adaptations, mice born from nutrient restrictive pregnancies have
smaller fat mass at birth (30). In total calorie restriction models cultured adipocytes from
post-natal day 1 have increased hyperplasia, hypertrophy, and increased protein
expression of lipogenic transcription factors (31). Increased proteins involved in
glucocorticoid signalling that regulate the mobilization of energy stores are also increased
in female, but not male, MNR offspring (29). Such adaptations could promote energy
storage during postnatal development to accommodate for reduced fat stores.
Skeletal muscle is another metabolically important tissue that is developed into the
postnatal period, and adaptations in growth restricted offspring include reduced muscle
mass and fiber type switching. Often growth restricted fetus’ have reduced oxidative type
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I fibers which are more insulin sensitive (22,32). Some muscle groups like the soleus
muscle have decreased cross-sectional area of type II fibers relative to controls (32).
Although myofiber surface area is decreased, the number of myoblasts (progenitor cells
that can differentiate and fuse to form myotubes) were similar to controls (32). Despite
maintenance of proliferative capacity when cultured in vitro, myoblasts have reduced
expression of a proliferation marker (Ki-67) in vivo (32). Regulation of in vivo myoblast
proliferation and changes in fiber types are influences by protein uptake, blood flow and
oxygenation which are reduced in muscles, such as the biceps femoris of growth
restricted fetuses (33). This maintenance of capacity to proliferate could allow the fetus to
adjust muscle mass if nutrient or oxygen levels are restored during development.
These tissue-specific fetal adaptations can promote immediate survival. Additionally,
they could function to predict the postnatal environment in order to enhance survival of
that offspring to a reproductive age. In the latter case, as described by the “predictive
adaptive response hypothesis”, these adaptations would be beneficial only if the postnatal
environment is accurately predicted (34,35). For example, increased insulin sensitivity in
peripheral tissues can accommodate for hypoinsulinemia due to nutritional scarcity.
Similarly, reduction in energetically demanding skeletal muscle and an increased
capacity for proliferation adipocyte proliferation, can promote energy conservation and
storage. Conserving and storing energy are an advantage in a nutrient restrictive
environment. However, if the environment proceeding the period of developmental
placidity does not match that predicted, such as a nutrient abundant one, these changes
can be maladaptive to long-term health.

Changes in Adult offspring in Response to Fetal Growth
Restriction
Adaptations in animal models of growth restriction produce changes that influence adult
metabolism. As adults, offspring are predisposed to glucose intolerance, insulin
resistance, reduced energy requirement per body weight gain, reduced activity, increased
appetite and/or increased preferences for fatty foods (16,30,36,37). Although model
variations exist, male offspring tend to be more prone to changes in glucose metabolism
and female offspring to adiposity (38,39).
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Liver-specific changes are in both glucose and lipid metabolism. Increased transcription
of genes involved in lipogenesis and decrease in proteins involved in cholesterol
clearance are associated with steatosis in offspring from fetal undernutrition (20,40).
Glycogen deposits are also increased in adult offspring from growth restricted
pregnancies (41). In normal tissues, insulin receptor activation by binding of insulin
results in increases IRS-2 and Akt phosphorylation, which increase glucose uptake and
glycogen synthesis and prevent hepatic glucose output. However, in IUGR rats from
placental insufficiency insulin stimulation does not result in increased phosphorylation of
IRS-2 or AKT or suppression of hepatic glucose production (42). Although increased free
fatty acids (FFAs) can contribute to hepatic insulin resistance, insulin resistance has been
detected in the absence of dyslipidemia (42). These data suggest that fetal undernutrition
results in offspring with insulin desensitization and an aberrant energy balance in the
liver that favors storage of lipids and glycogen.
Adult offspring also have changes in adipocyte size, number and/or growth. Increased
percent body fat has been observed with and without changes in body weight (20,43).
Offspring from 50 % maternal nutrient restriction late in gestation have increased
lipogenic gene expression and increased adipocyte size (44). Conversely, moderate
maternal nutrient restriction throughout pregnancy is associated with an increased
number but smaller adipocytes in female offspring (38). Decreased insulin sensitivity can
also occur in adipose tissue when growth restriction extends into lactation, but impact
males rather than females (39). Enhanced growth and inflammation in adipose tissue can
also influence differences in body mass and insulin sensitivity (30). Such studies suggest
that fetal adaptations to undernutrition can influence adult body mass composition, and
glucose and lipid metabolism in a sex-specific and model-specific manner.
Changes in body composition are also associated with reduced lean mass. Similar to the
growth restricted fetus, reduced muscle area and type I fiber number can persist into
adulthood (45,46). Premature aging by telomere shortening and DNA damage has also
been observed in the vastus lateralis muscle of aged prenatal protein restricted rats (47).
Decreased p-AKT to AKT ratios in response to insulin have also been observed in adult
male offspring from maternal protein restriction, suggesting impaired insulin sensitivity
in skeletal muscle (39). Reduced mass, insulin sensitivity and aging in skeletal muscle
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could contribute to aberrant glucose tolerance, reduced lean mass and insulin resistance
in adult offspring, increasing risk metabolic disorders.

Growth Restriction and Postnatal Diets
Adaptations in growth restricted offspring can impact responses to stress. High caloric,
high-fat (HFD) or high-fat high-sugar (HFHS) diets in animal models can mimic the
‘western diet’, a calorie dense diet that is high in saturated fat and refined sugars. Such
diets, in combination with fetal changes to conserved energy due to fetal undernutrition,
lead to further dysfunction in glucose and lipid metabolism and behavior. Growth
restricted offspring are more susceptible to diet-induced obesity and adipose tissue
inflammation (30). In part, due to increased lipogenesis in adipose tissue and decreased
cholesterol clearance in the liver, which leads to ectopic lipid accumulation and increase
serum lipids (31,48–50). Both ectopic lipids and serum FFAs are associated with
decreased insulin sensitivity (51). Although sedentary behavior is observed in some
models of IUGR, postnatal HFD diets can further reduce activity in offspring(16). These
studies suggest that growth restricted offspring are maladapted to a nutrient abundant
diet.

Hypoxia Signalling
One pathway activated in response to cellular stress such as low oxygen or nutrient over
or under abundance, is hypoxia-inducible factor (HIF) signalling. In physiologically
normal oxygen tension, oxygen is available for prolyl hydroxylases (PHDs) to
hydroxylate the oxygen degradation domain (ODD) of the a subunit (HIF-1, 2 or 3 a)
(52). Hydroxylation to the ODD of the a subunit allows recognition by the pVHLcontaining ubiquitin ligase and degradation by the proteasome (53). In the absence of
oxygen, the unhydroxylated a subunit can dimerize with HIF-1b. The HIF dimer can
then translocate to the nucleus and transcriptionally regulate genes containing hypoxic
response elements (HREs) (54) (Figure 1.4.1) . In addition to PHD hydroxylation, HIFa
stability and transcriptional activity can be modulated by phosphorylation, hydroxylation,
and ribosylation in the ODD, C-terminal and N-terminal transactivation domains (CTAD, T-TAD) which are regulated by oxygen and nutrient availability (17,53,55). HRE-
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containing genes are involved in pathways important in stress response as well as normal
development including metabolism, angiogenesis, proliferation and apoptosis (54).

Figure 1.4.1 Regulation of HIF Alpha Subunits in Hypoxia and Normoxic
Conditions.
Under normoxic conditions, the alpha subunit is hydroxylated by PHDs in the oxygen
degradation domain, resulting in recognition and degradation by the proteasome. In
hypoxia, oxygen is not available for hydroxylation and the alpha subunits are stabilized.
Stable alpha subunits can dimerize with the beta subunit, translocate to the nucleus, and
regulate expression of genes containing hypoxia response elements (HRE).

Hypoxia Signalling in Animal Models
Maternal hypoxia has been well documented to cause fetal growth restriction but recent
evidence suggests that other models of growth restriction can lead to hypoxic signalling
in placental or fetal tissues (56-58). Maternal nutrients and maternal protein restriction
result in placental adaptations that could decrease oxygen delivery to fetal tissues and
directly cause fetal hypoxia. In mice, the placenta can be divided into two functional
zones, the junctional and labyrinth zone. The junctional zone is involved in endocrine
signalling and energy storage and the labyrinth zone is the site of oxygen and nutrient
exchange. In growth restricted models, the zone most often impacted is the junctional
zone (59). Additionally, the placental weight relative to fetal weight ratio is increased and
oxygen tension was not different in growth restricted placentas (56). Availability of
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nutrients is known to modulate hypoxia signalling in vitro. In addition to oxygen, iron is
required for PHD hydroxylation of the HIFa subunits. Pathways in nutrient sensing, such
as GSK-3b, have also been implicated in regulation of a subunit stability or activity
(53,57). Together these data suggest that fetal nutrition may mediate hypoxic signalling
through redistribution of fetal circulation and nutrient signalling pathways and could
potentiate fetal adaptations to growth restriction.

Hypoxia Signalling in Pregnancies Complicated with
IUGR
Evidence of increased hypoxia-inducible signalling is present in placentas from IUGR
with preeclampsia, however, induction of this pathway in pregnancies with IUGR only
are inconsistent across studies (55,60). Similar to animal models of growth restriction,
some placentas from intrauterine growth restriction exhibit no changes in HIF proteins
(62). Whether hypoxia signalling may be induced in developing fetal tissues in human
IUGR pregnancies is currently unknown. It is possible that HIFs are differentially
regulating development or organ function, influencing perinatal and adult health.

Thesis Rationale
In this study we aimed to identify transcriptional changes that are associated with fetal
adaptations and/or changes in adult glucose metabolism in offspring from maternal
nutrient restriction (MNR) (70% ad libitum food) in mice, and how the postnatal diet may
modulate these changes. To isolate fetal undernutrition to pregnancy, without having an
impact on litter size or postnatal nutrition, maternal food restriction was applied postimplantation (E6.5) until birth and all litters were cross-fostered to ad libitum fed
mothers. Unpublished work from our lab has shown that male, but not female, offspring
develop glucose intolerance at 6 months of age. Despite detection of glucose intolerance,
there was no difference in serum insulin which suggests peripheral insulin desensitization
rather than insulin deficiency. Additionally, other models have shown males are
vulnerable to changes in insulin sensitivity of peripheral tissues (39). Subsequently, male
offspring were the focus in this study. The liver, adipose tissue and skeletal muscle are
metabolically important peripheral tissues that have been impacted in other models of
growth restriction (39,42) and could mediate long-term changes in glucose tolerance. To
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this end, fetal and adult liver, as well as skeletal muscle and visceral adipose tissue in
adults were assessed for changes in gene expression. This study is also unique because
adult organs collected for gene expression analysis are from mice that underwent
metabolic testing. Knowledge of the metabolic status for each mouse could aid in
identifying relevant transcription changes to the biological outcome. While other models
exist to study these tissues in nutrient restricted animals, most are in rats, guinea pigs and
larger mammals (22,37,63). A mouse model will allow further studies to genetically
manipulate identified genes and determine the role in fetal survival or offspring glucose
metabolism. Understanding the mechanism underlying associations between fetal
nutrition, growth restriction and adult metabolism will assist in identifying and treating
IUGR most at risk for adult metabolic disorders.
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Hypothesis and Objectives
Hypotheses: Changes in expression of genes regulating metabolism or tissue development
in liver, adipose and/or skeletal muscle occur in response to fetal nutrient restriction and
contribute to an altered adult glucose metabolism. We also hypothesized that a HFHS
will amplify the changes in metabolism in maternal nutrient restricted (MNR) offspring.
Objective 1: Metabolically assess outcomes of maternal nutrient restriction in adult
offspring.
Aim one: Characterize the impact of MNR on offspring adult glucose metabolism
when maintained on a standard diet chow post-weaning.
Aim two: Determine the effects of fetal undernutrition with a post-weaning highfat high-sugar (HFHS) diet in adult offspring.
Objective 2: Identify transcripts differentially expressed throughout the life of MNR
offspring in metabolically important tissues.
Aim one: Determine whether differential expression of genes regulating
metabolism or tissue development occurred in E18.5 liver in response to MNR.
Aim two: Assess differential expression of genes regulating glucose metabolism in
adult liver, skeletal muscle and adipose tissue.
Objective 3: Evaluate protein levels of differentially expressed genes involved in hypoxia
signalling in fetal liver.
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Introduction
Fetal growth restriction (FGR) or intrauterine growth restriction (IUGR) is a pregnancy
condition where the fetus fails to achieve optimal growth expected for gestational age
resulting in a small for gestational age (SGA) newborn with birth weight of <10th
percentile. The most common causes include maternal malnutrition in developing
countries and placental insufficiency in developed countries (1). Irrespective of the cause,
poor macro- and micro-nutrient and substrate concentrations in the fetus are a common
pathophysiological finding. Growth restricted infants are at increased risk for morbidity
and mortality in the perinatal period (2). As adults IUGR populations are also at
increased risk for chronic diseases including cardiovascular diseases (3), metabolic
disorders such as type 2 diabetes and glucose intolerance (3), and obesity and abnormal
lipid metabolism (4).
Associations between poor fetal growth and adult health and disease have led to the
concept of Developmental Origins of Health and Disease (DOHaD). The theory of
DOHaD proposes that environmental exposures, such as nutrient restriction, during
development can result in metabolic adaptations that enhance the survival of the fetus but
increase the risk for metabolic disorders as children and adults (5). The concept
underlying the association between poor fetal nutrition and predisposition to adult
diseases is termed the “thrifty phenotype hypothesis”(5).
Fetal growth restriction has been studied using maternal nutrient restriction in animals
such as rats (6–8) and guinea pigs (9), or larger mammals like pigs (10,11). These models
providing a short lifespan or similar morphology and diet to humans, respectively, and
insight into long and short-term changes in IUGR offspring. Genetic manipulation in
offspring to identify genes and epigenetic changes moderating impacts of fetal nutrition
are limited. Such limitations can be addressed by using maternal nutrient restriction in
mice.
Models of growth restriction in rodents by manipulating maternal nutrition provide
insight into certain types of fetal undernutrition in humans, either due to the onset of
placental insufficiency or food availability. For example, nutrient restriction prior to and
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throughout pregnancy in rodents (9,12) model mothers that experience extended
nutritional deficits. However, these models would not mimic fetal undernutrition due to
placental insufficiency. Conversely, nutrient restriction beginning later in gestation may
imitate insufficient placental development (6). Nutrient restriction just after implantation
in the mouse at E6.5 has not been studied and would be more similar to early- to midgestation-onset placental insufficiency.
Evidence suggests that metabolic adaptions to fetal undernutrition are tissue-specific and
serum peptides for obesity and diabetes can aid in identification of impacted tissues.
Incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent
insulinotropic peptide (GIP), are released by the gut upon ingestion of food and stimulate
release of insulin (13,14). Insulin and glucagon are pancreatic hormones that regulate
tissue glucose uptake and energy utilization. In addition to hormone release, c-peptide,
the cleaved portion of proinsulin, can indicate changes in insulin maturation (15). Leptin,
resistin (16) and plasminogen activator inhibitor (PAI-1) (17) are secreted primarily from
adipose tissue in mice. Leptin and ghrelin, which is released from the gut, regulate
appetite (18,19). Changes in these markers in addition to other metabolic tests can
provide insight into tissues with metabolic adaptations.
The objective of this study was to establish a moderate total calorie nutrient restriction in
mice to mimic human FGR populations and examine the long-term metabolic
complications. We hypothesized that a 30% reduction in maternal food consumption by
weight during early and late pregnancy would result in reduced fetal and newborn weight
and tissue-specific alterations in adult glucose metabolism similar to humans.

Methods
Animals
The animal experiments were conducted as approved by the Council on Animal Care at
the University of Western Ontario. All mice received free access to water in a standard 12
h light/dark cycle. Eight-week-old virgin female CD-1 mice, obtained from Charles River
Laboratories (Montreal, PQ, Canada), were mated. The presence of mucous plugs
indicated E0.5. After mating mice were housed individually. To avoid reduction in the
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number of conceptuses of each litter, mated females received ad libitum food until after
embryo implantation at about E5. At E6.5, the mice were randomly assigned into two
groups, the control group was fed ad libitum and the maternal nutrient restriction (MNR)
group was fed 70% average ad libitum total calorie intake (both groups receiving #F0173,
Bio-Serv, Flemington, NJ). At E18.5, 3 control and 3 MNR pregnant females were
euthanized by CO2 narcosis. No differences between the number of males and females
were observed between MNR and control litters (Supplementary Table 2.2.1). Litter
size ranged from 6 to 22 pups. To control for variations in litter size only litters with 1115 pups were analyzed in fetal (Control litters = 3, MNR litters = 3) and long-term
studies (Control litters = 5, MNR litters =10). Because many studies suggest that male
offspring are more sensitive to maternal undernutrition (20–22) and that postreproductive changes complicate long term studies in females (23), only males were
examines in this study. PCR of the SRY gene, which is located on the y chromosome and
is important in sex determination in mice, (forward primer TGGACTGGTGACAARGCTA, reverse primer - TGGAAGTACAGGTGTGCACTCT)
was used in fetal studies to include males only (Control N=21, MNR=15). Right liver
lobes were snap frozen in liquid nitrogen.
For postnatal studies, pups’ paws were tattooed at birth to track weights for each pup with
the Armis Microtatoo kit (Braintree Scientific, Inc., Braintree, MA). To assess impacts of
reduced nutrition during fetal development without the influence of nutrition during
lactation, all litters were cross-fostered to females that were fed ad libitum throughout
pregnancy and the litters were culled or fostered to 13 pups each. Since MNR resulted in
similar male-to-female ratios to control litters, the sex of pups was selected randomly
(Supplementary Table 2.2.1). Ad libitum standard chow (Teklad LM-485 Mouse/Rat
Serializable Diet, Mississauga, ON, Canada) was used for the remainder of the study in
both MNR and control offspring .
At weaning (P21) only male offspring were kept for further study (Control litters N=5,
MNR litters N=10) and were housed with 3 to 5 siblings per cage (Figure 2.2.1) Weight
was measured once a month. With the exception of littermates used for the intrahepatic
portal vein insulin challenge, offspring at 1 month (control N=12, MNR N=19, 1-2 pups
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per litter) and 6 months (control N=30, MNR N=52, all remaining pups) were euthanized
with CO2 narcosis. Weight was measured and serum was collected via intracardiac
puncture. Individual liver lobes, perigonadal adipose tissue, and quadriceps femoris were
collected, snap frozen in liquid nitrogen, and stored at -80°C until analysis. Seven-month
old animals used for the intrahepatic portal vein insulin challenge (N=8 per group) and
were euthanized after tissue collections.

Glucose Tolerance and Hepatic Glucose Production
Glucose tolerance was assessed in 36 MNR (10 litters) and 25 controls (5 litters, 3-8
pups/litter) one week prior to tissue collections or pyruvate challenge test at 6 months by
intraperitoneal glucose tolerance testing (IP-GTT). Briefly, fasted mice (4 h) (at 8 00 am)
were injected with glucose 2 g/kg body weight and blood glucose was measured via tail
vein every 30 minutes for 2 h using a Freestyle Lite Glucometer (Abbott, Alameda, CA).
At 6 months, hepatic glucose output was measured with a pyruvate challenge test (5 pups
per group, 1 pup/litter). Pyruvate was injected (IP) into mice fasted for 4 h (at 8 00 am) at
2 g/kg body weight and blood glucose was measured via tail vein every 30 min for 2 h.

Random Blood Glucose
From 1 to 6 months, monthly random blood glucose (non-fasted) was measured. Blood
samples were collected at 10:30 am via tail vein prick and measured using a Freestyle
Lite Glucometer (Abbott, Alameda, CA).

Intrahepatic Portal Vein Insulin Challenge Test
Seven months-old mice were fasted for 4 hours and anaesthetized with isoflurane. Insulin
stock was diluted 100X into sterile saline (Humalin R, Eli Lilly Canada Inc., Toronto,
ON Canada, 100U/mL). Using a mid-line incision, intestines were moved to expose the
hepatic portal vein and 2 U/kg of insulin (Control and MNR N=5, 1 pup/litter) or saline
(Control and MNR N=3, 1 pup/litter) was injected. After 1 minute and 15 seconds, a
piece of right medial liver lobe, a quadriceps femoris muscle and perigonadal fat were
frozen in liquid nitrogen. Samples were store in -80°C until western blot analysis (24).
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Protein Isolation
Fifty mg of frozen liver and muscle and 100 mg of adipose tissue were pulverized
(Medium Bessman Tissue Pulverizer, Spectrum Laboratories, Rancho Dominguez, CA)
and then homogenized for 30 seconds with the Brinkmann Homogenizer Polytron® 3000
in 1x Cell Lysis Buffer (9803S, Cell Signaling Technology® Inc., Danvers, MA) and
protease inhibitor cocktail 1, 2, and 3 (P1860, P5726, and P0044, Sigma-Aldrich, St.
Louis, MO, USA). The homogenate was then sonicated (F550 Sonic Dismemberator,
Fisher Scientific, Markham, ON Canada) and rocked for 40 minutes at 4°C. Samples
were spun at 12,000 x g for 10 minutes at 4°C. Supernatants were collected, with care not
to collect the lipid layer, and stored at -20°C until analysis. Protein quantification was
done with the Bio-Rad Protein Assay according to the manufacturer’s protocol using
BSA standards (Cat #500-0006, Bio-Rad Laboratories Inc., Des Plaines, IL).

Western Blotting
Protein samples were boiled in sodium dodecyl sulfate (SDS) sample loading buffer with
0.1M dithiothreitol (DTT) at 75 °C for 5 min then incubated on ice for 5 minutes. 10 μg
of protein was loaded and run on a 10% SDS polyacrylamide gel. Proteins were
transferred to a polyvinylidene difluoride (PVDF) membrane using the Trans-Blot®
Turbo™ Transfer System and Trans-Blot® Turbo™ RTA Midi Transfer Kit (170-4273,
Bio-Rad Laboratories Inc., Des Plaines, IL) according to the manufacturer’s protocol.
Once the transfer was completed, membranes were dipped in methanol and blocked with
5% milk in TBST (TBS + 1 % tween). Blocking buffer was rinsed from the membrane
for 5 min (3x) with TBST at room temperature (RT). Primary antibody for p-AKT
(#4000, rabbit mAB, Cell Signaling Technology® Inc.) was diluted 1:1000 into 5% BSA
in TBST and incubated with blots shaking at overnight at 4°C. Membranes were rinsed
with TBST 3 x (5 min.) at RT and then incubated with secondary rabbit IgG (#170-6515,
Bio-Rad Laboratories Inc., Des Plaines, IL) diluted 1:10,000 in 5% milk in TBST for 1
hour at RT. After rinsing the secondary antibody, ClarityTM Western ECL Substrate (1705061, Bio-Rad Laboratories Inc., Des Plaines, IL) and a VersaDoc Imaging System (BioRad Laboratories Inc., Des Plaines, IL), was used to capture an image of the gel.
Membranes were then rinsed and stripped with 0.5M NaOH, rinsed in TBS (3 x 5 min at
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RT) and reprobed with AKT (#9272, Bio-Rad Laboratories Inc., Des Plaines, IL),
according to the protocol above.
Quantification of blots was done using Imagelab software® version 5.1 BETA (Bio-Rad
Laboratories Inc., Des Plaines, IL) and quantities were compared using p-AKT to total
AKT ratios.

Serum Peptide Markers for Obesity and Diabetes
Blood samples collected by intracardiac puncture at 1 (Control N=7, MNR N=18, 4
control and 10 MNR litters, 1-2 pups/litter) and 6 months (5 control and 10 MNR litters,
3-7 pups/litter, MNR N=52, control N= 30) in non-fasted mice (8 30 - 9 30 h) were used
in this multiplex assay. At the time of collection, protease inhibitors, 10mM DPP-IV
(EMD Millipore, DPP4-010) and 1.3% aprotinin inhibitor (EMD Millipore, 616399) in
0.9% sterile saline, were added to the blood samples (10uL/mL). Samples were allowed
to clot for 45 minutes and spun at twice at 12 000 x g for 10 minutes to obtain serum. All
serum samples were stored at -80°C. Ghrelin, leptin, insulin, glucagon, PAI-1, GLP, GIP
and resistin were assayed on the Bio-rad Multiplex at Lawson’s Multiplex Facility,
London, ON, using the Bio-Plex Pro Mouse Diabetes Assay (171F7001M, Bio-Rad
Laboratories Inc., Des Plaines, IL). Serum C-peptide was also quantified according to the
manufacturer’s protocol (Mouse C-Peptide ELISA, 80-CPTMA-E1, Alpco, Salem, NH).

Lipid Quantification in Serum and Liver
An aliquot of non-fasted serum as described above was used to for cholesterol
(Cholesterol Quantification Kit MAK043, Sigma-Aldrich®, St. Louis, MO) and
triglyceride quantification (Triglyceride Quantification Assay Kit ab65336, Abcam®,
Cambridge MA). Liver cholesterol was also isolated from non-fasted liver tissue and
quantified according the manufacturer’s protocol. Measurements were taken from 5
control and 10 MNR litters, 3-6 pups/litter.

Statistical Analysis
Data are presented as mean ± SEM or as whisker plots (median and data range in
quartiles). For glucose tolerance testing, pyruvate challenge tests and random blood
glucose measurements a repeated measures ANOVA and Bonferroni post hoc correction
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was used. For all other analyses, a Mann-Whitney test was used to compare means where
samples sizes were > 8, and an unpaired t-test with £ 8 samples. Means are considered
significantly different if p < 0.05. All statistics and graphs were produced in Prism
software (Graphpad®, version 5.2), or the R console (version 3.3.2) with ggplot2 (version
2.2.1) and sciplot (version 1.1-0) software packages.

Weaning
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Control N= 12
Control
Offspring
N=67

Control
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Weighed
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10 litters
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Liver-to-Organ Weights
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pups/litter)

Control
Offspring
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Offspring

8 litters (11-15
pups/litter)

N=8, 1 pup/litter Insulin or saline injected
N=8, 1 pup/litter

Hepatic Portal
Vein Insulin
Challenge

Figure 2.2.1 Litter and Pup Sample Size for Postnatal Studies.

Results
Maternal total-calorie nutrient restriction (MNR) resulted in a 13% reduction (p = 0.001)
in fetal weight at E18.5 in males (Figure 2.3.1A), and 14% reduction (p = 1.5 x 10-8) in
birth weight of males (Figure 2.3.1B), relative to controls. E18.5 weight did not vary
significantly with position relative to blood supply (p = 0.4) (Supplementary Figure
S2.3.1). Body weights are not significantly different in MNR offspring between day 3 of
life and 6 months (Figure 2.3.1C), except at 1 month (p = 0.006) when controls (23.5 ±
0.4 g) were heavier than MNR (22.3 ± 0.3 g). This protocol demonstrated a reproducible
fetal growth restriction from moderate maternal nutrient restriction.
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In addition to body weight, organ weights were measured at each dissection. Fetal liverto-body weight ratio was 1.4-fold reduced in MNR offspring (0.05 ± 0.003) relative to
controls (0.07 ± 0.002, p < 0.0001), indicating a disproportionate effect of maternal
nutrition on the liver (Figure 2.3.2A). All other organs were proportionally reduced with
body weight. At one-month liver weight relative to body weight was similar in MNR
offspring (0.053 ± 0.005) (p = 0.09) (Figure 2.3.2B) but decreased again by 6 months
(0.039 ± 0.004) (p = 0.03) compared to controls (0.057 ± 0.008 and 0.042 ± 0.006, at 1
and 6 months respectively). The disproportionate impact on the liver growth suggests the
effects of fetal nutrition extend into adulthood (Figure 2.3.2C).
Whole body glucose metabolism and hepatic glucose output was assessed with IP-GTT
and pyruvate challenge tests, respectively. Reduced AUC in 6-month-old MNR offspring
(1553 +/- 57) relative to controls (1323 +/- 68, p = 0.045) demonstrated impaired glucose
tolerance (Figure 2.3.3A and B). Fasting blood glucose at the time of GTT did not differ
in MNR offspring (p = 0.3) (Figure 2.3.3A). Blood glucose at all time points and the
AUC for pyruvate challenge testing (Supplementary Figure S2.3.2) indicated similar
hepatic glucose output in MNR offspring relative to controls. Therefore, moderate
differences in glucose metabolism were detected in the MNR offspring.
Random blood glucose was measured once a month until 6 months of age. MNR
offspring had similar blood glucose to controls each month (p = 0.4) and the AUC did not
differ (p = 0.3) (Figure 2.3.4).
Serum peptide markers for diabetes and obesity were also assayed at one and six months
of age. At one month, PAI-1 was 1.9-fold higher in MNR offspring relative to controls (p
= 0.04) (Figure 2.3.5A i). PAI-1 remained higher in six-month MNR offspring (1.5-fold)
(p = 0.04) (Figure 2.3.5B i). Increased resistin was also detected at 6 months in MNR
offspring (189.8 + 9.8 ng/mL) relative to controls (171.2 + 14.5 ng/mL, p = 0.04)
(Figure 2.3.5B v). C-peptide, insulin-to-glucagon ratio, GIP, GLP, ghrelin and leptin did
not differ based on maternal nutrition at one and six months (Figure 2.3.5).
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In addition to peptide markers, lipids were measured in serum and the right lateral liver
lobe at 6 months. No differences were observed between control and nutrient restricted
offspring in serum triglycerides (p = 0.6) (Figure 2.3.6 Ai) or total cholesterol (p = 0.7)
(Figure 2.3.6 Aii). Additionally, control and MNR offspring had a similar liver
cholesterol (p = 0.07) (Figure 2.3.6 B).
A hepatic portal vein insulin challenge was used to examine tissue-specific insulin
sensitivity. Relative to controls, the p-AKT to AKT ratio was increased 2.5-fold in the
liver of MNR offspring in response to the insulin injection (p = 0.004) (Figure 2.3.7A).
Although not significant, insulin stimulated phosphorylation of AKT in adipose tissue
(Figure 2.3.7B) and skeletal muscle (Figure 2.3.7C) was not significantly different in the
nutrient restricted offspring, respectively (p = 0.08 and 0.05 respectively).
While changes in glucose metabolism occurred to some extent in all MNR offspring,
there was a variation in the degree of response to fetal nutrient restriction on adult
glucose metabolism. At 6 months, 19% of the offspring were less tolerant to glucose
(Figure 2.3.8A) and had a higher AUC than any controls (Figure 2.3.8B). The remaining
MNR have AUCs that were similar to those of controls.
Serum peptide analysis in the less tolerant mice showed increased insulin (p = 0.006),
leptin (p = 0.001) (Figure 2.3.9G), and resistin (p = 0.005) (Figure 2.3.9F) levels, with
no changes in other assayed peptide markers (Figure 2.3.9).
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Figure 2.3.1 Body weights of MNR and Control offspring from E18.5 until 6
months.
At E18.5, fetal weights of MNR (N=15) were 13% smaller than controls (N=20) (p =
0.001) (3 Control and 3 MNR litters, 3-8 pups per litter) (a). Birth weight of MNR
offspring remained 14% smaller (p = 1.5 x 10-8) (Control N=39 from 5 litters, MNR
N=58 from 10 litters, 4-9 pups/litter) (b). Except at 1 month when controls were heavier
than MNR (p = 0.005), no differences were observed in weight from day 3 to 6 months.
From birth-1-month, Control N= 37 and MNR N= 52 from 5 control and 10 MNR litters
(3-11 pups/litter). From 2 months-6 months, Control N= 27 and MNR N=36 from 5
control and 10 MNR litters (3-9 pups/litter) (c). Growth curve data is plotted as the mean
+ SEM. Asterisk represents significance (p < 0.05) with a Mann-Whitney test.
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Figure 2.3.2 Organ weights of male offspring at E18.5, 1 month and 6 months.
(a) At E18.5, liver weight was reduced in MNR offspring relative to their body weight (p
< 0.0001) (Control N=20 and MNR N=15, 3 litters/group, 3-8 pups/litter). (b) Relative to
body weight the liver of MNR offspring was similar to controls at 1 month (p = 0.09)
(control N=12 from 5 litters, MNR N=19, 9 litters, 1-3 pups/litter) and significantly lower
at 6 months (p = 0.03) (control N= 24, MNR N=30, 5 control and 10 MNR Litters, 3-8
pups/litter). (c). Fetal data are mean + SEM (a). Asterisk represents a p < 0.05 with a
Mann-Whitney test.
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Figure 2.3.3 IP-GTT of male offspring at 6 months.
Blood glucose at 90 and 120 minutes were significantly higher in MNR offspring (N=36,
10 litters) relative to controls (N= 25, 5 litters, 3-8 pups/litter) (a). The AUC was also
significantly higher (p = 0.045) (b). Glucose tolerance data (a) are mean + SEM. Asterisk
represents a p < 0.05 with a Bonferroni post hoc (a) or Mann-Whitney test (b).
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Figure 2.3.4 Random blood glucose in male MNR and control offspring from 1 to 6
months of age.
(A) Random blood glucose did not significantly differ at age. (B) AUC from random
blood glucose was similar between MNR and control indicating normoglycemia in MNR
offspring. At 1 month Control N= 33, MNR N= 51 (5 control and 10 MNR litters, 3-11
pups/litter); from 2 months-6 months Control N= 26, MNR N=36 (5 control and 10 MNR
litters, 3-9 pups/litter). Data are mean + SEM (a) or whisker plots (b). Asterisk represents
a p < 0.05 with a repeated measures ANOVA(a) or Mann-Whitney test(b).
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Figure 2.3.5 Serum peptide markers for obesity and diabetes.
Peptides were measured at (a) 1 month (Control N=7, MNR N=18, 4 control and 10
MNR litters, 1-2 pups/litter), and (b) 6 months of age (5 control and 10 MNR litters, 3-7
pups/litter, MNR N=52, control N= 30). PAI-1 was increased in MNR offspring at 1
month (p = 0.04) and 6 months (p = 0.04), (i) and resistin at 6 months (p = 0.04) (v).
Ghrelin (ii), GLP-1 (iii), leptin (iv), GIP (vi), insulin to glucagon ratios (vii), and Cpeptide (viii) levels were similar between control and MNR offspring. Data are presented
as the median and quartiles in whisker plots. Asterisk indicates a p < 0.05 with a MannWhitney test.
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Figure 2.3.6 Serum and liver lipids in male MNR (N=36) and control (N=27)
offspring at 6 months of age.
A. Serum triglyceride (p = 0.6) (i) and total cholesterol (ii) (p = 0.7) were not
significantly different between MNR and control offspring. B. Liver total cholesterol was
also similar between MNR and control offspring (p = 0.07). 5 control and 10 MNR
litters, 3-6 pups/litter. Data are mean + SEM (a). Asterisk represents a p < 0.05 with a
Mann-Whitney test.
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Figure 2.3.7 Insulin signalling as determined by phosphorylation of AKT in
response to an insulin bolus in male MNR and control offspring at 7 months of age.
p-Akt relative to AKT after an insulin dose was increased in MNR offspring relative to
controls in the right medial liver lobe (p = 0.004) (a). p-AKT to AKT ratios were
relatively increased in MNR adipose tissue and (b) skeletal muscle of insulin injected
mice, but this change was not significant (p = 0.08 and 0.05, respectively) (c). Saline
injected N=3 and insulin injected N=5 for both maternal nutrition groups (5 control and 8
MNR litters, 1 pup/litter). Western blots were done in quadruplicates. A representative
blot and quantification of the replicates are shown with whisker plots. Means with
different letters are significantly different (p < 0.05, unpaired t-test).
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Figure 2.3.8 Glucose tolerance tests for all MNR and control offspring at 6 months.
(a) Individual glucose tolerance tests for controls demonstrate the range of responses. (b)
7 MNR (black) had an AUC under the curve greater than other MNR or controls (grey)
(c) which are referred to as intolerant MNR (5 control and 10 MNR litters, 3-8
pups/litter).
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Figure 2.3.9 Serum peptide markers for obesity and diabetes in male MNR and
control offspring at 6 months old according to glucose tolerance.
Resistin (p = 0.005) (d) and leptin (p = 0.001) (e) were significantly increased in MNR
offspring that are glucose intolerant. PAI-1 (a), Ghrelin (b), GLP-1(c), GIP(f),
insulin:glucagon (g) and c-peptide (h) were not significantly different in intolerant MNR.
Control N=30 (5 litters, 3-8 pups/litter), tolerant MNR N=43 (10 litters, 3-8 pups/litter)
and intolerant MNR N=7 (5 litters, 1-2 pups/litter). Asterisk represents a p < 0.05 with a
Mann-Whitney test.
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Discussion
In humans, FGR can be symmetric or asymmetric. Symmetric FGR, meaning all organs
are reduced proportionately to body weight, is often associated with an insult of earlyonset (25). Conversely, asymmetric FGR is more common in late-onset growth
restriction, and is where less essential organs are reduced but vital organs such as the
brain and the heart are spared (25). Similar to humans, maternal undernutrition in mice
resulted in an asymmetric growth restriction and had the most significant impact on the
liver (26). The thymus and spleen are also smaller relative to body weight in SGA
autopsies (26) but were not measured in this study. Although reduced again at 6 months,
one-month relative liver weights were similar to controls which might indicate
differences in growth rate of the liver in MNR offspring. MNR in guinea pigs do not
result in reduced liver-to-fetal weight ratios but fractional growth rates are increased near
term (9). These data suggest that liver growth may be more sensitive than other organs to
fetal undernutrition.
The variation in response to fetal nutrient restriction in our model was similar to the
variations observed in the human FGR populations. Some individuals with extremely low
birth weights (ELBW) although having 3 times greater risk will not develop glucose
intolerance and type 2 diabetes(3). In adults, genetic variation and differential expression
contribute to obesity and metabolic disorder resistant and/or susceptible populations of
non-human primate (27) and rodent models (28,29) in response to nutritional stress, such
as a high fat diet. Offspring in models exposed to a maternal high fat diet or nutrient
restriction have metabolic (7,30), gut microbe (31) and epigenomic changes (32), but to
our knowledge none of these models focus on changes specific to susceptible and
resistant populations in these offspring. Having glucose tolerant and intolerant offspring
resulting from MNR allow future studies to examine adaptations in glucose metabolism
within the MNR populations and in all offspring exposed to nutrient restriction in utero.
In this study, normal glucose tolerance observed in 81% of the offspring might have been
due to increased insulin sensitivity as adults despite having smaller livers. Increased
insulin sensitivity is present at birth and persists a few weeks postnatally in lambs
exposed to hypoxia-induced placental insufficiency (33). To our knowledge, evidence of
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insulin desensitization (6,7) has been observed rather than persistence of the increased
sensitivity into adulthood. Intolerant MNR offspring, which had relatively higher insulinto-glucagon ratios, could have insulin resistance that was not detectable during insulin
sensitivity test due to the limited sample size. Studies comparing liver responses in
intolerant and tolerant MNR mice may provide insight into why some offspring are able
to adapt to the postnatal parameters assessed in this study.
Despite having similar body weight at 6 months, PAI-1 and resistin levels were increased
in MNR offspring. Both are produced primarily in adipose tissue in mice (16,17) and are
associated with obesity and low-grade chronic inflammation (16,17,34). Individuals born
SGA with the highest body mass index (BMI) have reduced insulin sensitivity (35).
However, total fat pads are increased in female adult rats that experienced 50% nutrient
restriction throughout gestation with similar adult body weights to controls (36). ELBW
babies have also have similar BMI with increased body fat mass (3). Subsequently,
increased markers for obesity and meta-inflammation may indicate reduced lean mass in
male offspring in response to fetal undernutrition even with similar adult body weights.
MNR offspring with glucose intolerance had higher serum resistin, and it cannot be
excluded that increased fat mass may contribute to the development of glucose
intolerance.
Leptin was also increased in intolerant offspring. Serum leptin is correlated with body fat
mass in humans (37) and mice(38), supporting the notion of differences in body
composition. This marker could also indicate a decreased appetite in less tolerant MNR
offspring. Alternatively, leptin resistance occurs in diet-induced obesity (39) and
increased leptin in offspring with impaired glucose homeostasis may be a sign of leptin
resistance. Leptin may also play a role in regulation of energy expenditure (39) and
behavior changes, such as food preference and total activity. These behaviors are also
altered in adulthood following IUGR or undernourishment during development (40,41).
Increased serum leptin levels suggest that behaviors or body mass composition may be
altered in susceptible MNR offspring and require further investigation.
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Moderate nutrient restriction throughout gestation resulted in changes to the liver and
adipose tissue including decreased fetal liver weight and increased adult insulin
sensitivity in the liver. Serum markers for body mass composition and meta-inflammation
were also increased. The liver is important in regulation of lipid and glucose metabolism
and a key tissue in the development of type 2 diabetes. While it is possible that some
adaptations occur in all offspring exposed to MNR, additional physiological and
biochemical changes in the liver or other organs may be specific to those that develop
glucose intolerance. This model provides an opportunity to investigate the tissue-specific
molecular mechanism underlying changes between control and MNR as well as
susceptible and resistance offspring. The variation in MNR offspring represents the
diversity in human FGR populations and their susceptibilities towards type 2 diabetes
(3,4).
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Chapter 3 : High-Fat High-Sugar Diet Impairs Offspring
Glucose Tolerance Independent of Poor Maternal Nutrition in
Mice

This chapter was submitted for consideration as a brief report in the Journal of
Developmental Origins of Health and Disease (ID: DOHaD-11-18-BR-1072).
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Introduction
Intrauterine growth restriction (IUGR) is a pregnancy condition where fetal growth is
suboptimal, resulting in an infant born small for gestation age (<10th percentile). These
infants have increased risk for perinatal morbidity and mortality (1), and as adults are
more likely to develop obesity and type II diabetes (2,3). Common causes of IUGR
include maternal malnutrition and placental insufficiency, both resulting in fetal nutrient
restriction (4). It is thought that the fetus may adapt metabolically to enhance survival in
a nutrient restrictive environment, but these adaptations may persist to adulthood where
nutrients are abundant and increase the risk for metabolic diseases. This concept is
termed the “thrifty hypothesis” (5).
Modulation of the post-weaning diet may mediate these long-term effects. Studies have
shown that ‘catch-up’ growth is associated maladaptive effects on glucose metabolism,
and that dietary prevention of ‘catch-up’ growth is metabolically protective (6). A postweaning nutrient-rich diet provides a larger mismatch between fetal and post-natal
environments that will increase ‘catch-up’ growth, worsening glucose intolerance and
obesity (7).
In humans and animals, a high caloric diet is associated with insulin resistance and type II
diabetes (7,8). Different types of high caloric diets have been studied including high fat,
fructose, sucrose, or to a lesser extent combination diets (9,10). While controversy exists
on which type of diet is most harmful, excess calories seem to be important in metabolic
disease promotion (8, 11). Regardless of the challenge, it is thought that fetal and adult
diets can potentially interact and impact long term health. The data described in this
report indicate a post-weaning high-fat high-sugar (HFHS) diet can disrupt adult glucose
metabolism and overcome differences in offspring exposed to maternal undernutrition.

Methods
Animals
All animal handling was completed within the University of Western Animal Ethics
Guidelines (2017-033). Maternal nutrient restriction was used as described by Radford
and Han, 2018 (12). Briefly, virgin 8-week-old female CD-1 mice were mated and
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vaginal plugs indicated E0.5. At E6.5 pregnant mice were randomly assigned to ad
libitum-fed controls or maternal nutrient restriction (MNR) (70% of ad libitum total
calories)( #F0173, Bio-Serv, Flemington, NJ) until E18.5. Litters with 11-15 pups were
cross-fostered to ad libitum-fed mothers. Fostered litters were culled or fostered to 13
pups. At weaning, female offspring were euthanized and male offspring were randomly
assigned to standard chow (Standard) or a high-fat high-sugar diet (HFHS) (Harlan
TD.88137) (Table 3.2.1). The four groups studied were Control:Standard,
Control:HFHS, MNR:Standard and MNR:HFHS (Figure 3.2.1).
Weights were measured once a month from 1 to 6 months. Monthly non-fasted blood
glucose was also measured (1030 h) using a tail vein puncture and the Freestyle Lite
Glucometer (Abbott Laboratories, USA) (Control:Standard N= 25, MNR:Standard N=36,
Control:HFHS N=33 and MNR HFHS N=52) (Figure 3.2.1).

Table 3.2.1 Composition of Post-Weaning Diets.
Diet

Standard
Chow
(Teklad
LM-485)
HFHS-diet
(Harlan
TD.88137)

Protein (% Carbohydrates Fat (%
calories)
(% calories)
calories)
25

17

58

15

43

42

Fat composition (% of
diet)
0.8 saturated
1.3 monounsaturated
2.9 polyunsaturated
- cholesterol
13 saturated
6 monounsaturated
1 polyunsaturated
0.2 cholesterol

Sucrose
(% by
weight)
30

12

Metabolic caging
At 2 (N=4 per group) and 7-months (N=5 per group), metabolic analysis was assessed
using the Comprehensive Lab Animal Monitoring System (CLAMS) with the Oxymax
software (Columbus Instruments, Columbus, OH, USA) at the Robarts Research Institute
(Figure 3.2.1). Mice were individually caged and acclimated for 16 hours. During the
acclimation and measurement periods, cages were maintained at 24 ± 1 °C and mice
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received free access to food and water. Measurements of respiratory exchange ratio
(RER), food consumption, heat, and total activity were obtained every 10 minutes for 24h
(12-h light/12-h dark), as previously described (13). Briefly, VO2 and VCO2
measurements were normalized to body weight (mL/kg/h) and used to calculate RER
(VCO2/VO2). The use of pure carbohydrates as a metabolic substrate would result in a
RER of 1 and exclusive fat oxidation would be 0.7. Heat produced was also calculated
with VO2 and RER [VO2 x (3.816 +1.232 x RER)]. To assess activity, infrared beam
breaks were monitored. Total activity is the sum of ambulatory activity or consecutive
breaks along the x and y axis, and stereotypy activity which is beam breaks that do not
meet ambulatory threshold.

Glucose Tolerance and Pyruvate Challenge Tests
For 6-month intraperitoneal glucose tolerance tests (IP-GTT), mice fasted for 4h (starting
at 8 00 h) were injected intraperitoneally with glucose (2 g/kg). Blood glucose was
measured at 0, 30, 60, 90 and 120 minutes via tail vein (Control:Standard N= 25, MNR:
Standard N=36, Control:HFHS N=39, Control:HFHS N=63) (Figure 3.2.1). After one
week of recovery, pyruvate challenge was completed with the same protocol as IP-GTT
but pyruvate was injected at a dose of 2 g/kg (N=5 per group) (Figure 3.2.1).

Statistical Analysis
All statistical and graphical analysis were completed in Graphpad Prism (version 5.2 and
8). Mean body weights between groups were compared with a Mann-Whitney test. A
two-way repeated measures ANOVA with a Bonferroni post-hoc was used to compare
means from random blood glucose, glucose tolerance and pyruvate challenge tests. All
data collected from metabolic caging was analyzed with a two-way ANOVA and a
Bonferroni post-hoc test.
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Figure 3.2.1 Litter and Sample Size Summary for MNR Offspring on a PostWeaning Standard Chow or HFHS diet.
A cohort of male offspring on a post-weaning high-fat high-sugar (HFHS) from 19 MNR
and 10 control litters was assessed for body weight, random blood glucose and glucose
tolerance (A). Five offspring from separate litters were placed on a standard chow diet at
weaning and compared to a littermate on a HFHS diet in metabolic cages (2 and 7
months) and with a pyruvate challenge test (6 months) (B). A second cohort was
produced with 5 control and 10 MNR litters to measure body weight, random blood
glucose and glucose tolerance. Tissues from 1 and 6 months were also collected for
studies not describes in this chapter. Note: the number of pups on the HFHS diet declined
between 2 and 7 months due to mortality or ulcerative dermatitis.
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Results
Birth and weaning weights of MNR offspring prior to exposure to a post-weaning HFHS
diet were discussed in chapter 2. Weights of MNR and controls were similar from 1 to 6
months on a HFHS diet. Weight from 1 to 6 months was significantly higher in HFHSfed offspring relative to those on standard chow (1 month Control:Standard and
MNR:HFHS p = 0.03, and all other p < 0.0001) (Figure 3.3.1A).
Random blood glucose measurements from 1 to 6 months did not differ significantly
between maternal nutrition groups in HFHS-fed offspring. However, blood glucose levels
were significantly increased from 1 to 5 months in HFHS-fed mice compared to standard
chow-fed offspring (Figure 3.3.1B). These findings suggest that post-weaning diet, but
not maternal nutrition, had an impact on growth and random blood glucose in the
offspring.
Glucose tolerance and hepatic glucose output were assessed with IP-GTT and pyruvate
challenge tests, respectively. No differences in glucose tolerance were detected in
between maternal nutrient groups within the same diet (Figure 3.3.1C). All HFHS-fed
offspring had higher a blood glucose relative to those fed standard show in response to a
glucose bolus at all time points (Figure 3.3.1C). AUCs for Control:HFHS (1001 ± 54.52)
and MNR:HFHS (1126 ± 36.02) offspring during 6 month IP-GTT was higher than
controls (538 ± 51.06) and MNR (692.2 ± 55.75) on standard chow fed offspring (p <
0.0001) (Figure 3.3.1D). Hepatic glucose output during a pyruvate challenge test did not
differ significantly between maternal nutrition status with similar post-weaning diets
from 0-120 minutes (Figure 3.3.1E). Similar AUCs were also measured for control (811
± 208.6) and MNR (762.4 ± 227.9) on HFHS (p = 0.88) (Figure 3.3.1F). These data
suggest that a HFHS diet decreased glucose tolerance and caused a relative increase in
hepatic glucose output in response to pyruvate (Figure 3.3.1); regardless of prenatal
condition.
Metabolic cages were used to compare post-weaning diets (HFHS and standard chow) or
maternal nutrition (MNR and control). At 2 (Figure 3.2.2A) and 7 months (Figure
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3.2.2B), a post-weaning HFHS diet significantly decreased RERs (2 month: light-cycle p
= 0.01, dark-cycle p = 0.002; 7 month: light-cycle p = 0.0001, dark-cycle p = 0.0001),
and increased heat produced (2 month: light-cycle p = 0.0001, dark-cycle p = 0.003; 7
month: light-cycle p = 0.005). Maternal nutrient restriction significantly decreased 2month food intake during the day (p = 0.007) and activity at night (p = 0.01) (Figure
3.2.2A). Seven-month-old MNR offspring also had reduced RER during light-cycle (p =
0.04). There was no significant interaction between post-weaning diets and maternal
nutrition in any parameters measured.
Post hoc tests of metabolic parameters were used to compare MNR and control offspring
on a HFHS diet. At 2 months, no differences in respiratory exchange ratios (RERs) or
heat production were detected between Control:HFHS and MNR:HFHS(Figure 3.3.2A i
and ii). Food consumption during the day was decreased in MNR:HFHS (6210 ± 572.5
kCal) relative to Control:HFHS (9866 ± 545.1) (p = 0.004) (Figure 3.3.2A iii). No other
parameters measured were significantly different between control and MNR on standard
chow (Figure 3.3.2A) or on either diet at 7 months (Figure 3.3.2B).
In addition to changes from maternal diet, effects of post-weaning diets in offspring with
similar maternal nutrition was assessed. At 2 months, MNR offspring RERs were
significantly lower on a HFHS (day= 0.8525 ± 0.01702, night= 0.8975 ± 0.019) relative
standard chow (day= 0.94 ± 0.014 , night = 0.9900 ± 0.0041) during the day (p < 0.05)
and night (p < 0.01) (Figure 3.3.2A i) and maintained to 7 months (daytime HFHS=
0.8460 ± 0.018 and standard chow= 0.9500 ± 0.0084, nighttime HFHS= 0.8800 ± 0.018
and standard chow= 0.9840 ± 0.014) (p < 0.01 and 0.001, respectively) (Figure 3.3.2B i).
Decreased RERs in Control:HFHS relative to Control:Standard were only evident at 7
months during both light and dark-cycles (p < 0.05 and 0.01 respectively). (Figure 3.3.2
A i). In 2-month-old control:HFHS diet had increased heat production (daytime= 0.5925
± 0.026, nighttime = 0.6240 ± 0.0433) relative to controls on a standard chow diet during
the light and dark-cycle (daytime = 0.4800 ± 0.01080, nighttime = 0.5120 ± 0.01655, p <
0.01) (Figure 3.3.2A ii), which was maintain at 7 months during the light-cycle (p <
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0.05). Heat produced was increased in 2-month old MNR:HFHS (0.5550 ± 0. 0.01848)
compared to MNR:Standard (0.4700 ± 0.02449) during the day (p < 0.01), but was not
maintained at night or 7 months. No other significant differences were detected between
maternal nutrition on a similar post-weaning diet.
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Figure 3.3.1 Weight and blood glucose regulation in MNR and control offspring.
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A. Body weight was measured from 1 to 6 months. At one month, MNR were
significantly smaller than controls on a standard chow diet (p = 0.006). No other
differences were detected between maternal nutrition, but all offspring on a HFHS diet
had significantly higher body weight relative to offspring fed standard chow (p < 0.05).
B. MNR had similar random blood glucose to control offspring on similar post-natal
diets. HFHS-fed offspring had significantly higher random blood glucose from 2 to 4
months relative the same maternal diet group fed standard chow. MNR on a HFHS diet
also had higher blood glucose at 5 months compared to MNR on standard chow.
(Control:Standard N=25, MNR:Standard N=36, Control:HFHS N=33, MNR:HFHS N=
52). C. Glucose tolerance did not differ between control and MNR on similar diets and
normalized blood glucose at all timepoints were higher on the HFHS diet-fed offspring
compared to standard chow fed offspring from similar maternal diets. (Control:Standard
N=25 , MNR:Standard N=36, Control:HFHS N=39, MNR:HFHS N= 63) D. Pyruvate
challenge tests showed hepatic glucose output did not differ between control and MNR
on similar diets, or between diets from the same maternal nutrition at all timepoints (N=5
per group, 1 pup/litter in each group). Data are expressed as mean ± SEM. Man Whitney
tests (A, Cii and Dii) or a two-way repeated measures ANOVA with a Bonferroni posthoc was used (B, Ci and Di). Different letters represent significant differences between
maternal nutrition and asterisks represent significant differences between diets within the
same maternal nutrient group.
Sample numbers per month are as followed for A:
Month
Control:Standard MNR:Standard
1
37
52
2
28
37
3
28
37
4
28
37
5
28
37
6
28
37

Control:HFHS
52
44
43
43
42
39

MNR:HFHS
82
68
73
71
66
64
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Figure 3.3.2 Metabolic caging data from 2 (A) and 7 (B) month-old offspring during
the day (light cycle) and night (dark-cycle ).
At two months, RER (A i) was significantly lower in MNR fed HFHS diets than MNR
fed on standard chow at both light cycles (p = 0.002 and 0.03, respectively). Controls on
a HFHS produced more heat than controls on standard chow during the day at 2 months
(p = 0.01) (A ii). Control:HFHS consumed more food than MNR:HFHS (p = 0.004)(A
iii) and total activity was decreased in MNR relative to controls on a HFHS diet (p =
0.03) (A iv). In 7-month-old offspring RERs were reduced in MNR fed HFHS diets
compared to MNR fed on standard chow at both light cycles (B i, p = 0.01 and 0.02,
respectively). No other differences were detected at 7 months. Data are presented as the
mean ± SEM). A two-way ANOVA was used to compare post-weaning and maternal diet
or interactions between these parameters and the p-values are shown in the chart beside
each graph. Bonferroni multiple comparisons were used for any changes detected and
significant differences (p <0.05) are represented by an asterisk. 2 month N=4 and 7
month N= 5 per group (1 mouse per litter).

60

Discussion
The concept of a ‘second hit’ such as a dietary challenge or sedentary life style is
essential to the “Thrifty Phenotype Hypothesis”, where the fetus is primed to conserved
nutrients but experiences a nutrient abundant post-natal environment. A HFHS diet was
used in this study to mimic the western diet and investigate the role of a ‘second hit’ in
the adult males. The MNR males were expected to have reduced glucose tolerance and
insulin sensitivity compared to controls. However, MNR offspring showed no differences
in glucose tolerance, hepatic glucose output, random and fasting blood glucose, RER,
food consumption or activity compared to controls on a HFHS diet.
Moderate nutrient restriction during pregnancy resulted in similar body weights in
adulthood compared to controls on standard chow or HFD. Rat offspring from 50%
maternal nutrient restriction late in gestation that were a fed standard chow (14) or a HFD
(14,15) after weaning have also resulted in similar adult body weights to offspring from
control pregnancies on the same postnatal diet. Increased growth of fat mass and
phenotypic switching of pro-inflammatory macrophages (16) have been observed without
changes in body weight and could impact the tissue function in MNR offspring.
Conversely, mice with low maternal protein or calorie restriction throughout pregnancy
became more obese than offspring from control pregnancies (17,18). This variation might
be due to timing of catch-up growth, with catch-up growth prior to day 3 which was
previously observed in this model (12) or after weaning (19) having a protective effect
against diet-induced obesity. Additionally, although diet composition varied, daily calorie
consumption was similar in all experimental groups, except at 2 months when
MNR:HFHS ate less than Control:HFHS. If higher calories were consumed differences
between MNR and control might have been observed.
Maternal diet during pregnancy had no impact on non-fasting random blood glucose,
glucose challenge or pyruvate challenge in our mouse offspring on a HFHS post-weaning
diet. Rat offspring from low maternal protein throughout pregnancy and lactation or
intrauterine artery ligation weaned into a HFD resulted in no significant differences in
glucose tolerance (17,20), fasting and non-fasting blood glucose (20). Islet aging was
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similar from a maternal HFD and maternal low protein, suggesting that both
environmental exposures may converge on similar mechanisms (20). A similar
mechanism underlying HFD exposure and reduced maternal nutrition could explain why
there were no significant interactions in metabolic assessments and similar blood glucose
regulation in MNR and control offspring fed a HFD. Conversely, evidence of maternal
undernutrition with (15) and without (14) a high a caloric post- weaning diet causing
decreased insulin sensitivity (14,15,21) or alterations in expression of hepatic genes
important in gluconeogenesis (22) have been observed. The age of ‘catch-up’ growth and
total calories consumed may have minimized differences between control and MNR
offspring on HFHS.
MNR on a HFHS diet showed decreased RERs at all ages and time points relative to
MNR on standard chow, but this decrease was only significant in controls at 7 months.
Pure carbohydrates as an energy source would result in a RER of 1 and oxidation of only
fats would be 0.7. Reduced RERs imply decreased carbohydrate and increased use of fat
as a metabolic substrate. Some studies indicate that nutrition during weaning or gestation
impact RER only when stimulated with metabolic regulatory peptides such as
adiponectin or leptin (21,23), which have not been assessed in this study. Stimulation by
adiponectin or leptin may have been required to detect significant differences between
maternal nutrition on the same diet or at other ages and time points.
A calorie dense post-weaning diet did not significantly impact activity levels of offspring
at 2 or 7-months old. Activity was also similar between control and MNR groups within
the same post-weaning diet. Consistent with our results, no changes in energy
expenditure from a calorie dense or standard chow diet were also observed in rat
offspring from early gestation maternal nutrient restriction compared to controls (21).
Both suboptimal nutrition during early development and a high caloric adult diet have
been associated with increased appetite, changes in food preference and sedentary
behavior (14,18,21,23,24). Conversely, restriction of nutrients during lactation by
increasing litter size (23), adjusting maternal diet (18) or preconception maternal diet (24)
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could have a greater impact on such behaviours compared to maternal nutrition alone. In
fact 50% maternal nutrient restriction minimized sedentary behaviour induced by a HFD
(14). In addition to minimal impact from maternal nutrition, diet did not lead to
significant changes in food intake or activity. Rat offspring from maternal nutrient
restriction resulted in increased caloric intake and reduced activity (21), suggesting that
total calories rather than dietary composition could influence total activity. While the
amount of food consumed did not differ in MNR offspring, preference for dietary intake
of high fat or high sugar diets was not measured and cannot be eliminated in this study.
Because maternal nutrient restriction was limited to pregnancy and offspring did not
consume excess calories on the HFHS diet, changes to activity and food consumption
were not observed in MNR offspring relative to controls.
Moderate maternal nutrient restriction during gestation in mice did not result in
differences in metabolic parameters measured in this study in response to a post-weaning
isocaloric HFHS diet. The timing of the ‘second hit’ as well as the total calories
consumed may have contributed to minimal interaction with maternal diet. However,
MNR on standard chow started out with increased insulin sensitivity (12) and have
similar abilities to regulate blood glucose on the high fat diet. A use of fat as a metabolic
substrate was also more evident in MNR offspring at all time points, indicating that they
may have been more impacted than controls. This study demonstrates differences due to
maternal nutrition and the interaction with diet composition without excess calories and
sedentary activity. Additionally, it underlines the importance of dietary composition in
adult life.
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Chapter 4 : Evidence of Increased Hypoxia Signalling in
Fetal Liver from Maternal Nutrient Restriction in Mice
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Introduction
Intrauterine growth restriction (IUGR) is a pregnancy condition where fetal growth is
suboptimal, resulting in an infant born with a birth weight <10th percentile (1).
Individuals born from pregnancies complicated by IUGR are at increased risk for periand post-natal complications, and as adults are at increased risk for metabolic disorders
(2,3). Adverse intrauterine conditions may lead to adaptations to enhance fetal survival
but contribute to aberrant metabolism as adults (2).
Hypoxia inducible factor (HIF) pathway is a cellular response to enhance survival in
adverse conditions such as hypoxia and nutritional stress. Under normal physiological
conditions, the a subunit (HIF-1a, HIF-2a, HIF-3a) is post-translationally hydroxylated
and/or phosphorylated in the cytosol by regulators such as von Hippel–Lindau (VHL)/U3
ligase complex, factor inhibitor of hypoxia (FIH) and glycogen synthase kinase 3b (GSK3b) (4–6). These post-translational modifications promote proteasomal degradation (4–6).
During cellular stress, reduced hydroxylation and/or phosphorylation at stabilization sites
inhibit recognition by the proteasome. Stabilization in the cytosol results in increased
dimerization with the HIF-1b subunit. HIF dimers then translocate to the nucleus and
transcriptionally regulate genes containing hypoxia responsive elements (HREs)(7).
HRE-containing genes are involved in metabolism, cell cycle regulation and angiogenesis
(5,7).
Changes in HIF signalling in placentas from growth restricted pregnancies (8) or kidney
and liver of maternal nutrient restricted IUGR animal models have been documented (8–
11). However, others fail to find differences in HIF signalling in these tissues (9,12).
Previously we have shown that maternal nutrient restriction results in male offspring with
reduced fetal and adult liver size and increased hepatic insulin sensitivity in adulthood
(13). Here we aimed to investigate whether HIF signalling has a role in fetal liver
adaptations after exposed to moderate calorie restriction in utero.
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Methods
Animals
All animal procedures were approved by the Animal Use Subcommittee of the University
Council on Animal Care at the University of Western Ontario and were described by
Radford and Han, 2018(13). Briefly, mice were housed in 12-hour light and dark cycles.
Virgin 8-week-old CD-1 female mice were bred, and the presence of a vaginal plug
indicated E0.5. At E6.5, pregnant females received ad libitum standard chow (control,
N=5) or maternal nutrient restriction (MNR, N=5) (70% total calories) (both groups
receiving #F0173, Bio-Serv, Flemington, NJ). At E18.5 dams were euthanized with CO

2

narcosis and pups with cervical dislocation. Right liver lobes were removed from each
pup, snap frozen in liquid nitrogen and stored at -80°C. Only male fetuses were identified
with SRY PCR (forward primer - TGGACTGGTGACAARGCTA, reverse primer TGGAAGTACAGGTGTGCACTCT) and used for further analysis.

RNA isolation
RNA for sequencing was isolated from 10 control and 10 MNR livers (2 mice per litter).
Additional RNA from 8 control and 8 MNR littermates (1 or 2 mice per litter) were used
as a validation cohort for real time PCR. Briefly, the frozen right liver lobe (30-50 mg
for sequencing and 10-15 mg for real time PCR) was pulverised with a Bessman Tissue
Pulveriser (Spectrum Laboratories, Rancho Dominguez, CA) then homogenized with a
Brinkman homogenizer Polytron® 3000 for 50 seconds in 1mL or 500uL of ice cold
trizol, respectively. The PureLink Mini RNA kit (Invitrogen, USA) with the on-column
DNAseI treatment protocol was used to collect RNA from homogenate, as described by
the manufacturer.

RNA sequencing
RNA/library QC and RNA sequencing was run at McGill University and Genome
Quebec Innovation Centre, Quebec, CA. Libraries were generated with the NEBNext®
Ultra™ Directional RNA Library Prep Kit for Illumina® (E7420S, New England
BioLabs, Massachusetts, United States). Quality of RNA was verified on the Agilent
Bioanalyzer (RIN > 7). Single-read 50bp sequencing was obtained from a HiSeq 2500
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with 17-31M reads per sample (average depth of 23M). Reads were aligned to the mm9
transcriptome (14) with Bowtie2 (15) (90% alignment rate).

Real time PCR
Complementary DNA was generated with the SuperScript™ IV First-Strand Synthesis
System (Invitrogen, USA). Taqman assays that covered multiple exons were purchased
for select target genes including: Cyclin G2 (Ccng2) (4448892, Mm00432394_m1), Bcell Translocator Gene 2 (Btg2) (4453320, Mm00476162_m1), Lysine Demethylase 3A
(Kdm3a) (4448892, Mm01182127_m1), FK506 Binding Protein (Fkbp5) (4448892,
Mm00487406_m1), 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 (Pfkbp3)
(4448892, Mm00504650_m1), Hypoxia Inducible Factor 3a (Hif-3a)
(Mm00469375_m1), von Hippel–Lindau (Vhl) (Mm00494137_m1), Hypoxia Inducible
Factor 1a (Hif-1a) (Mm00468869_m1), and Hypoxia Inducible Factor 2a (Hif-2a)
(Mm01236112_m1); and endogenous controls Glyceraldehyde-3-Phosphate
Dehydrogenase (Gapdh) (4331182, Mm99999915_g1) and beta actin (4331182,
Mm01205647_g1) (Invitrogen, USA). Reactions were run with TaqMan™ Fast
Advanced Master Mix (Invitrogen, USA) on the ViiA™ 7 (Applied Biosystems, USA)
according to the manufacturers protocol. Fold change was calculated using the delta delta
CT method (ddCT).

Protein Isolations
Ten-Fifteen mg of tissue was homogenized with 1mL of ice cold 1x Cell Lysis buffer
(9803S) from Cell Signaling (Danvers, MA, USA) with protease inhibitor cocktail 1, 2,
and 3 (P1860, P5726, and P0044, Sigma-Aldrich, St. Louis, MO, USA) for 40 seconds
with a Brinkman homogenizer Polytron® 3000. Lysates were sonicated (F550 Sonic
Dismemberator, Fisher Scientific, Markham, ON Canada) and then shaken at 4°C for 2
hours. Cellular debris was removed from lysates by spinning at 12,000 x g for 10 minutes
and the supernatant was collected for analysis. Protein concentrations were calculated
with the Bio-Rad Protein Assay (Cat #500-0006, Bio-Rad Laboratories Inc., Des Plaines,
IL) according to the manufacturer’s protocol.
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Western Blotting
Fifty µg of protein for HIF-2a blots and 25µg for all other blots were loaded and run on
an 8% polyacrylamide gel. Protein was transferred to a PVDF membrane with the
Transblot Turbo (Bio-rad Laboratories Inc., USA). Membranes were dipped in methanol
TM

and then blocked for an hour at room temperature in 5% milk in TBST. After rinsing 3
times (5 minutes each) in TBST, primary antibodies were incubated in 5% BSA in TBST
overnight (Table 4.2.1). Blots were rinsed 3 times (5 minutes each) and incubated with
secondary antibodies in 5% milk in TBST for 1 hour at room temperature (Table 4.2.1).
Blots were images with the Clarity Western ECL Substrate (1705061, Bio-Rad
TM

Laboratories Inc., Des Plaines, IL) and band intensities were quantified using Imagelab
software® version 5.1 BETA (Bio-Rad Laboratories Inc., Des Plaines, IL). Kdm3a was
not assessed via western blot because we were not able to find an effective antibody for
the mouse fetal liver samples. All sample lysates were run on three western blots to
generate technical replicates for statistical comparisons. Only one representative blot is
shown.

Statistical analysis
Samples that contributed more variation than expected to the each group were removed
as outliers as described by Gierliński et al. with the median plus 2 times the interquartile
range as the threshold (16). Differential expression was detected with a false discovery
rate (FDR) < 0.1 and detection in 2 or more tools (EdgeR(17), DESeq2(18) and
ALDex2(19)) using the default settings in R (version 3.4.3). Optimal number of clusters
were generated with the gap statistic with the Cluster library (version 2.0.6) and PCA
plots were plotted with ggplot2 (version 2.2.1) and ggrepel (version 0.8.0) in the R
console (version 3.3.2 and 3.4.3). Gene ontology (GO) pathway enrichment was done on
the Gene Ontology Tool (Panther)(20,21); and KEGG and NCI pathway enrichments
were run on enrichR (22,23). For quantitative PCR (qPCR) and western blots unpaired ttests were used to compare delta CT values or band intensities respectively on Graphpad
Prism (version 5.2).
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Table 4.2.1 Antibodies used for western blotting
Target
HIF-2a
HIF-3a
FKBP5
PFKFB3
Mouse IGG

Company
Santa Cruz Biotechnology Inc.
Santa Cruz Biotechnology Inc.
Santa Cruz Biotechnology Inc.
Cell Signaling
Bio-Rad Laboratories Inc.

Cat. No
sc-13596
sc-390933
sc-271547
13123S
170-6515

Dilution
1:250
1:200
1:200
1:1000
1: 10 000

Results
RNA sequencing data was assessed for sample outliers and gene distributions among
remaining samples (16). One control and one MNR sample contributed more variance to
their respective maternal nutrient groups than other samples within the group and were
removed from further analysis (Figure 4.3.1). With remaining samples, two distributions
of genes were formed along PC1 (Figure 4.3.2). The second distribution contained genes
enriched in GO pathways in neural and epithelial cell development (Supplementary
Table 4.3.1), since hepatocyte and hematopoietic populations are of primary interest in
this study this second distribution of genes was removed from the analysis.
Overall gene expression was explored with PCA (principal component analysis) plots and
cluster analysis. The optimal number of clusters with the gap statistic of the centered-log
ratio and regularized-log ratio transformed data was 1. However, k-means clusters with
k=2 resulted in clusters separating based on counts per sample (Figure 4.3.2A and
Supplementary Table 4.3.2). The PCA plot of the top 500 variable genes from the
centred-log ratio (Figure 4.3.3A) did not result in separation of samples based on
maternal nutrition. Regularized-log ratio transformed data PCA of the top 500 variable
genes indicates moderate separation of maternal nutrition along PC1. Although PC1 only
explains 8% of the total variance in the samples (Figure 4.3.3B). These data suggest that
overall gene expression was similar between control and MNR fetal livers.
Despite similar overall expression, 49 protein-coding genes were differentially expressed
in MNR fetal livers relative to controls using a false discovery rate (FDR) cut-off of < 0.1
and consistency of two or more tools (Supplementary Table 4.3.3). GO enrichment
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indicated negative regulation of transcription from RNA polymerase II promoter in
response to hypoxia as the top pathway when ranked according to fold enrichment
(Cited2 and Vhl) (Figure 4.3.4A). Hypoxia signalling was also the top pathway
enrichment according to combined scores with KEGG (Figure 4.3.4B) and NCI (Figure
4.3.4C). Additional genes included in these enrichments are Pfkfb3 and Hif-3a.
Investigation into gene functions of differentially expressed genes indicate further
involvement in cellular response to hypoxia (Figure 4.3.5 and Supplementary Table
4.3.4).
Genes involved in hypoxic regulation of metabolism, cell cycle regulation and chronic
hypoxia were selected to be validated by qPCR in a separate validation cohort (Figure
4.3.6). Pfkfb3 transcript was increased 1.8-fold (p = 0.002) in MNR relative to controls,
similar to the fold change in the RNAseq data of 1.5 (FDR = 1.2x10-6). Fkbp5 and
Kdm3a transcripts were also confirmed to be increased by 1.3 and 1.5-fold (p = 0.03 and
0.02) and similar to sequencing fold changes of 1.6 and 1.2, respectively (FDR = 0.006
and 0.04). Lastly, Hif-3a was significantly higher by 1.4-fold in the MNR livers in the
validation cohort (p = 0.01), similar to the 1.3-fold increased initial MNR cohort (FDR =
0.009). Although not significant, Ccng2, which was 1.5-fold higher in the RNAseq data
(FDR = 0.0001), was relatively higher in the MNR fetal livers by 1.4-fold (p = 0.05).
Btg2 and Vhl were not significantly different in the validation cohort (p = 0.1 and 0.7).
Hif-1a and Hif-2a transcripts were not significantly different in the initial MNR cohort,
but Hif-1a was 1.3-fold decreased in the validation MNR group used for qPCR relative
to controls (p = 0.01).
Protein levels for genes differentially expressed in the validation cohort, as well as HIF2a, were determined by western blots (Figure 4.3.7). HIF-1a was not detected in the
fetal liver (Supplementary Figure S4.3.1) but HIF-2a was increased 2.2-fold in MNR
fetuses (p = 0.002). HIF-3a was also increased by 1.3-fold (p = 0.03) in MNR relative to
controls (Figure 4.3.7A and B). FKBP5 and PFKFB3 protein levels were not
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significantly different between maternal nutrient groups (1.6 1.3-fold change, p = 0.09
and 0.5, respectively) (Figure 4.3.7C and D).
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A

B

Figure 4.3.1 Biplots of E18.5 liver RNA sequencing data transformed with the
centered-log ratio for controls (A) and MNR (B).
Group outliers are indicated by the red box. N=10 for both groups.
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Figure 4.3.2 Distribution of genes in the center-log ratio transformed data.
Two overlapping distributions of genes contributing to PC1 are visible on the biplot,
which are not separating based on maternal nutrition or litters (Group-Litter, Group=
Control (C) or MNR (M) and Litters= A to J) (A). Two clusters are formed (k-means)
(cluster 1 = grey, cluster 2 = black). Histograms of all rotation values (B i) with a black
box indicating rotation values between -0.004 and 0.004. Distribution 1(left) and 2(right)
are separated by the red line (B ii) in a histogram only showing rotation values between 0.004 and 0.004. Control N=9 and MNR N=9, 1-2 pups/litter.
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Figure 4.3.3 PCA of the top 500 variable genes.
Data was transformed with the centered-log ratio (A) and regularized log ratio (B).
Control N=9 and MNR N=9, 1-2 pups/litter.
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A

B.

C.

Figure 4.3.4 Top 10 gene ontologies (A), KEGG (B), and NCI:Nature (C) gene
pathway enrichments with protein-coding genes differentially expressed between
control and MNR.
For B and C, significant pathways are in red and the bar size represents the combined
scores.
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Figure 4.3.5 Genes differentially expressed in the RNAseq data (FDR <0.1 in 2 or
more differential expression tools) in hypoxic inducible factor signalling.
Upregulated, down-regulated or no change. Boxes indicate genes selected for qPCR in a
validation cohort, along with HIF-1a and HIF-2a.
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Figure 4.3.6. Relative fold change for genes involved in HIF signalling validated in
an additional cohort with qPCR.
Data are plotted as mean ± SEM and asterisks represent p < 0.05 with an unpaired t-test.
Control N=8 and MNR N=8, 1 or 2 pups/litter.
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Figure 4.3.7 Western blots of proteins confirmed to be differentially expressed in the
validation cohort.
HIF-2a (A) and HIF-3a (B) were significantly increased in MNR offspring by 2.2 and
1.3-fold (p = 0.002 and 0.03, respectively). FKBP5 (C) and PFKFB3 (D) were not
significantly different in MNR relative to controls (p = 0.09 and 0.5, respectively). All
blots were run in triplicates and representative blots are shown. Data are plotted as mean
± SEM and asterisks represent p < 0.05 with an unpaired t-test. Control N=6 and MNR
N=7, 1 or 2 pups/litter.
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Discussion
HIF-2a protein was increased in MNR offspring, but HIF-1a was not detected. Normal
development in cells, such as endothelial cells, involve a switch from HIF-1a to HIF-2a
as the primary HRE transcriptional regulator, similar to the transition observed with
chronic hypoxia in cancer cells (24,25). During the liver bud maturation the HIF-1a
transcript decline is associated with a shift in hepatoblast differentiation from biliary cells
to hepatocytes (26). Although not known, it is conceivable that the developing liver shifts
from HIF-1a to HIF-2a as well. In other tissues this switch is thought to occur in part
because oxygen tension increases as organ perfusion during development becomes more
efficient. FIH and PHDs less efficiently hydroxylate HIF-2a allowing it to stabilize and
accumulate longer than HIF-1a (27,28). Additionally, differential expression of miRNAs
can lead to decreased Hif-1a mRNA stability but not Hif-2a (29). HIF-1a and HIF-2a
have both redundant and non-redundant gene targets that depend on cellular context and
cell type (24,30). The presence of HIF-2a but not HIF-1a is likely due to the lategestational sampling in this study and duration of hypoxia signalling.

Hif-3a mRNA and protein were higher in MNR compared to controls. Hif-3a mRNA is
induced by HIF-1a during chronic hypoxia and transcriptionally down-regulates Hif-1a
as a negative feedback mechanism (31,32). In mice Hif-3a has three isoforms, a fulllength transcript and two variants, IPAS and NPAS. All three isoforms can inhibit the
transcriptional activity of HIFs by binding with HIF-1b or HIF-1/2a, preventing
dimerization and nuclear translocation (33). Some HIF-3a splice variants can also
weakly induce canonical HIF-1a target genes (34). Consequently, increased HIF-3a
protein could contribute to moderate differences between control and MNR HIF-induced
transcription.
Fkbp5 was also increased at the transcript level and, although not significant, relatively
increased at the protein level. FK506 Binding Protein (FKBP5) functions as co-chaperon
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to HSP90 and as a scaffold protein. Subsequently, FKBP5 has diverse functions including
reducing the affinity of glucocorticoid to the glucocorticoid receptor and promotion of
adipocyte differentiation (35,36). As a chaperone FKBP5 also promotes the folding of
PHLPP (a key phosphatase for AKT) resulting in reduced AKT phosphorylation (37). In
adipose tissue chronic hypoxia results in increased FKBP5 (36) and in hepatocellular
carcinoma cell lines sorafenib treatment resulted in HIF-2a-dependant induction of
Fkbp5 transcription (38). FKBP5 has also been shown to regulate CDK5 interaction with
DNMT1 and reduce DNA methylation activity (39). Most studies have been in neural
cells or adipocytes, but this study suggests that FKBP5 may play a role cellular stress in
the developing liver. An increase in FKBP5 could be induced by HIF-2a in MNR
offspring, influencing metabolism, cell growth and/or DNA methylation.
Changes to hypoxia signalling in the liver could be indirect through placental adaptations.
Decreased placental size could reduce oxygen and nutrient delivery, although the
junctional zone is more impacted than the labyrinth zone (40). In guinea pigs, MNR
results in increased hypoxyprobe-1 staining in both male and female liver and kidneys
(10). However, no differences were detected in the placentas (10). Alternatively, MNR
could increase HIF signalling in the developing liver through nutritional signalling and/or
changes to fetal circulation. Further studies into the mechanism of HIF signalling need to
be elucidated. However, increased HIF-induced transcripts support the concept that MNR
results in increased hypoxia signalling in the fetal liver.
Maternal nutrient restriction resulted in fetal expression changes in hypoxia-inducible
signalling pathways of E18.5 liver. Although expression changes were detected, the
protein levels of genes induced by HIF transcription factors were not significantly
different. Since tissue hypoxia declines during development (24, 26) it is possible that
downstream changes were more evident earlier in liver development. Still, due to their
importance in regulating multipotency, cell differentiation, and proliferation, HIFinduced transcription could result in differences in liver maturity and cell populations.
Additionally, differential expression of epigenetic regulators such as Kdm3a and Fkbp5
may prime HRE-containing genes to respond differentially to aging or nutritional
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abundance. Evidence of aberrant hypoxia signalling was evident in growth restricted
mice, but the impact was moderate which may relate to the duration of nutrient restriction
and the timing of analysis. Differentially expressed transcripts support the concept that
hypoxia signaling may play a role in growth restriction in response to fetal
undernutrition.
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Chapter 5 : Similar Gene Expression in Adult Liver, Adipose
Tissue and Skeletal Muscle of Maternal Nutrient Restricted
Offspring Susceptible or Resistant to Changes in Glucose
Metabolism

The following chapter contains a manuscript prepared for submission in PLOSone
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Introduction
Intrauterine Growth Restriction (IUGR) is a pregnancy condition where fetal growth is
suboptimal, resulting in an infant born with a birthweight <10th percentile. The most
common cause in developed countries is poor placental development (placental
insufficiency) and in under-developed countries is maternal malnutrition (1). In both
placental insufficiency and maternal malnutrition, the fetus is undernourished during
development and the gestation at which it is impacted depends on the timing and type of
pathology. In the short term, infants from IUGR pregnancies have higher morbidity and
mortality rates in the perinatal and neonatal periods (2). As adults, offspring from IUGR
pregnancies are also at increased risk for adult diseases such as cardiovascular disease,
glucose intolerance and type 2 diabetes (3).
Initial studies demonstrating convincing evidence between pathologically small birth
weights and long-term metabolic outcomes were in cohorts of the Dutch famine. Ravelli
et al (1998), described an increased occurrence of glucose intolerance in these adults
whose mothers experienced the Dutch famine during pregnancy (4). Further studies of
this population, other IUGR populations and animal models have also demonstrated an
influence of fetal environment on adult health (5–8). Such studies have led to the concept
of ‘Developmental Origins of Health and Disease’ (DOHaD). In this concept, adversity
during fetal and early life can lead to adaptations that may temporarily improve survival.
However, these adaptations may not be beneficial to those individuals as an adult (9).
One mechanism of fetal adaptation is through epigenetic changes such as DNA
methylation, histone modifications, and differential miRNA expression, which result in
altered gene expression that influence organ development or cell function in
metabolically important tissues. The epigenetic marks can persist until later in life
(adulthood) and may lead to altered gene expression and pathology.
The adaptations can be tissue-specific making animal models useful when studying longterm metabolic impacts of fetal undernutrition. Previous work in our laboratory has
established a mouse model of IUGR using maternal nutrient restriction (MNR) (10).
MNR male offspring from this model experienced growth restriction and had smaller
liver-to-body weight ratios (10). At 6 months, 19% of the MNR offspring were glucose
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intolerant and the remaining were not susceptible to glucose tolerance changes (10).
Despite the variation in glucose tolerance, most MNR had increased hepatic insulin
sensitivity (10). The aim of this study was to identify tissue-specific expression changes
that occur in response to fetal undernutrition in all MNR and/or in susceptible MNR
offspring. Liver, adipose tissue and skeletal muscle were the tissues of focus because
insulin sensitivity in these tissues precedes the development of type 2 diabetes (11).
Although at increased risk, not all individuals born from IUGR pregnancies will develop
metabolic disorders. Understanding the expression changes associated with susceptible
and resistant growth restricted populations to changes in glucose tolerance could help
identify IUGR populations in humans that will develop an altered glucose metabolism as
adults.

Methods
Animals
All animal care and procedures were approved by the Council on Animal Care at the
University of Western Ontario and as previously described (10). Briefly, pregnant CD-1
mice received ad libitum food or maternal nutrient restriction (MNR) (70% of ad libitum)
from E6.5 until birth. Only litters with 11-15 pups were studied and male to female ratios
did not vary between control and MNR litters (10). All pups were cross-fostered to an ad
libitum-fed mother at birth with litters culled or fostered to 13 pups per litter. Male
offspring were weaned onto a standard chow diet (Teklad LM-485 Mouse/Rat
Sterilizable Diet, Harlan Laboratories, USA). At 6 months, offspring were euthanized by
CO2 necrosis (8 30 to 10 00 h) and right medial liver lobes, perigonadal fat pads, and
quadriceps femoris were snap frozen in liquid nitrogen. Frozen tissues were stored at 80°C until further analysis.

RNA isolation
Fifty mg of liver (control N=8, intolerant MNR N=7, tolerant MNR N=8) and skeletal
muscle (control N=8, intolerant MNR N=9, tolerant MNR N=8) and 100 mg of adipose
tissue (control N=8, intolerant MNR N=9, tolerant MNR N=8) was pulverized and then
homogenized for 50 seconds in 1 mL of ice cold TRIzol (InvitrogenTM, Carlsbad, CA,
USA). RNA was extracted from homogenate with RNA PureLinkTM mini kit
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(InvitrogenTM, USA) according to the manufacturer’s TRIzol and on-column DNAseI
treatment protocol. RNA quality was verified (RIN ³ 7) with an Agilent Bioanalyzer
2100 at McGill University and Génome Québec Innovation Centre (Montreal, QC,
Canada) and the National Research Council Canada (NRC) (Saskatoon, SK, Canada).

RNA sequencing
Library preparation and quality control for the liver and skeletal muscle were done at the
McGill University and Génome Québec Innovation Centre (Montreal, QC, Canada) with
the Illumina TruSeqTM mRNA Stranded library kit (Illumina). Single-reads sequencing
was run on a HiSeq 2500 and the average read depth was 13 million per sample. Adipose
RNA libraries and QC were prepared by the National Research Council Canada (NRC)
(Saskatoon, SK, Canada) using the NEBNext® Ultra™ II Directional RNA Library Prep
Kit for Illumina®. An average of 8 million paired reads per sample were obtained. Reads
from all tissues were aligned to the mm9 transcriptome with Bowtie2 (12). Quality
control of reads and removal of adapters or primer sequences were done with the Trim
Galore (version 0.4.4) library.

Differential Gene Expression and Pathway Enrichment
Genes with no counts per samples were removed from count tables. Outlier detection,
PCA plots and differential expression were done in the R console (version 3.3.2) (13)
with Z Compositions (version 1.1.1) (14), CoDaSeq (version 0.99.1) (15,16) and ggplots2
(version 2.2.1) (17) libraries. Sample outliers in glucose tolerance groups with variation
greater than the median plus 2 times the interquartile ratio were removed, as described by
Gierliński et al. (Supplementary Figure S5.2.1-5.2.3) (18). The impaired fasting blood
glucose (IFBG) group, which exhibited higher blood glucose than any controls
(Supplementary figure S5.2.4), had a small sample size (N=4) and were not assessed for
outliers. EdgeR (19), DESeq2 (20), and Aldex2 (21) tools were used in differential
expression analysis and protein-coding genes were considered differentially expressed if
there was consistency in two or more tools (FDR < 0.1, > 2-fold change). Gene ontology
enrichment was done on the panther online tool (22,23), and NCI:Nature and KEGG
enrichment was done on the EnrichR online tool (24,25).
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Results
Gene expression of control and MNR offspring, as well as tolerant and intolerant MNR,
were assessed in the right medial liver lobe, quadriceps femoris muscle and perigonadal
adipose tissue at 6 months. PCA plots of expression data within each tissue suggest that
samples do not cluster based on maternal nutrition or glucose tolerance in all three tissues
(Figure 5.3.1 and Supplementary Figure S5.3.1). Sample-to-sample plots also
demonstrate that samples do not separate based on maternal nutrition or glucose tolerance
(Figure 5.3.2).
Although tissues showed similar overall gene expression, we examined pathway
enrichment of genes differentially expressed between maternal nutrition and glucose
tolerance groups (Table 5.3.1-5.3.3 and Supplementary Table 5.3.1). In the liver, 6
genes were differentially expressed in MNR offspring relative to controls (Table 5.3.1
and Supplementary Table 5.3.1). These genes include three heat shock protein
chaperons (Hspab1, Hspa11) as well as FGF11 which are involved in MAPK signalling.
Both heat shock proteins and Alas1 are also involved in the immune response to EpsteinBarr virus infections. Twenty four genes are differentially expressed in intolerant MNR
relative to controls (Table 5.3.1 and Supplementary Table 5.3.1) including three heat
shock proteins (Hspa1a, Hspa11, and Hsp1b) that are involved in cellular response to
heat, unfolded proteins, immune response, MAPK pathway (Ntrk2, Fgf11), and longevity
and estrogen signalling pathways (Adcy1). Pathway enrichment also shows differences in
intolerant MNR in tyrosine receptor signalling (Dnaic1, Pdk4, Gdf15, Hspb1, and Ntrk2)
and p53 effectors (Hspa1a, Fdf15). Although not indicated by pathways enrichment,
differentially expressed genes associated with obesity, lipid metabolism and adipogenesis
were increased (Vldlr, Adcy1, Ntrk2) or decreased (Cyp26b1) in intolerant MNR relative
to controls (26,27). Despite differential expression of 7 genes in MNR with impaired
fasting blood glucose, no pathways were enriched (Table 5.3.1 and Supplementary
Table 5.3.1). Similar to intolerant MNR, genes involved in lipid and cholesterol
metabolism were decreased (Cyp26b1, Mfsd2a, Cyp2b10)(28) in the impaired fasting
blood glucose cohort. Only metallothionein 1 was differentially expressed between
tolerant and intolerant MNR, and subsequently no pathways were enriched.
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Minimal transcriptome changes were evident in 6-month quadriceps femoris muscle
(Table 5.3.2 and Supplementary Table 5.3.1). Furthermore, no genes were
differentially expressed between all MNR and controls. Only 3 genes in intolerant MNR
and 4 genes in MNR exhibiting a higher fasting blood glucose and were differentially
expressed compared to controls. Potassium voltage-gated channel, shaker-related,
subfamily, member 6 (Kcna6) was differentially expressed between tolerant and
intolerant MNR. No pathway enrichment was found in differentially expressed genes
(Table 5.3.2).
In the adipose tissue differential gene expression analysis also revealed minimal
differences between control and MNR offspring (Table 5.3.3 and Supplementary Table
5.3.1). Napsin A aspartic peptidase (Napsa) was differentially expressed between all
MNR and controls. In the intolerant and impaired fasting blood glucose groups, 6 and 2
were differentially expressed between relative to controls, respectively. No genes were
differentially expressed between tolerant and intolerant MNR. None of the genes
differentially expressed in adipose tissue between maternal nutrition or glucose tolerance
groups were significantly enriched in pathways (Table 5.3.3).

96

Figure 5.3.1 PCA plots of liver (A), skeletal muscle (B), and adipose tissue (C)
demonstrate similar overall expression between control (grey) and MNR (black),
and between glucose tolerance groups (symbols).
Plotted data was transformed with the centered log ratio and filtered for the top 500
variable genes.
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Figure 5.3.2 Sample-to-sample plots of RNAseq centered-log ratio transformed data
from the liver (A), skeletal muscle (B), and adipose tissue (C).
Samples did not cluster based on maternal nutrition (Y-axis) or glucose tolerance (Xaxis).
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Table 5.3.1 Pathway enrichment of differentially expressed genes (FDR <0.1 in 2 >
tools) in the liver of 6-month offspring.
Reference Group

Comparison
Group

# Genes

GO Enrichment

KEGG Enrichment
MAPK signalling pathway
(20.24) (Hspb1, Hspa1l,
Fgf11)

All MNR

6

Control
Intolerant
MNR

24

NA

Protein refolding
(4.49E-03), Chaperone
cofactor-dependent
protein refolding
(1.04E-02), Cellular
response to unfolded
protein (4.14E-02),
Cellular response to
heat (4.07E-02)
(Hspa1a, Hspa1l,
Hspa1b)
Transmembrane
receptor protein
tyrosine kinase
signalling pathway
(2.56E-02) (Dnaic1,
Pdk4, Gdf15, Hspb1,
Ntrk2)

Tolerant MNR

MNR with
Higher
Fasting
Blood
Glucose
Intolerant
MNR

Epstein-Barr virus infection
(12.53) (Hspb1, Hspa1l,
Alas1)
MAPK signalling pathway
(29.20) (Hspa1a, Hspa1l,
Hspa1b, Ntrk2, Fgf11,
Hspb1)
Longevity regulating pathway
(27.42), Estrogen signalling
pathway (22.60) (Hspa1a,
Hspa1l, Hspa1b, Adcy1)
Antigen processing and
presentation (14.94),
Toxoplasmosis (13.94),
Measles (12.40), Spliceosome
(12.23), Influenza A (11.56),
Legionellosis (18.25)
(Hspa1a, Hspa1l, Hspa1b)

7

NA

NA

1

NA

NA

Note: Combined scores (KEGG and NCI:Nature) or FDR (GO) per pathway are
indicated in brackets, followed by the genes included in the pathway.
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Table 5.3.2 Pathway enrichment of differentially expressed genes (FDR < 0.1 in 2 >
tools) in skeletal muscle of 6-month-old offspring.
Reference Group

Control

Tolerant MNR

Comparison
Group
All MNR
Intolerant
MNR
MNR with
Higher
Fasting Blood
Glucose
Intolerant
MNR

# Genes

GO Enrichment

KEGG Enrichment

0

NA

NA

3

NA

NA

4

NA

NA

1

NA

NA

Note: Combined scores (KEGG and NCI:Nature) or FDR (GO) per pathway are indicated
in brackets, followed by the genes included in the pathway.

Table 5.3.3 Pathway enrichment of differentially expressed genes (FDR < 0.1 in 2 >
tools) in adipose tissue of 6-month-old offspring.
Reference Group

Control

Tolerant MNR

Comparison
Group
All MNR
Intolerant
MNR
MNR with
Higher
Fasting Blood
Glucose
Intolerant
MNR

# Genes

GO Enrichment

KEGG Enrichment

1

NA

NA

6

NA

NA

3

NA

NA

0

NA

NA

Note: Combined scores (KEGG and NCI:Nature) or FDR (GO) per pathway are indicated
in brackets, followed by the genes included in the pathway.
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Discussion
In our mouse model of fetal growth restriction, the overall gene expression in 6-monthold liver, adipose and skeletal muscle was similar for offspring of maternal nutrition
restriction and control pregnancies, and glucose tolerant and intolerant groups. Increased
p-AKT to AKT ratios in response to insulin occurred in the liver of most MNR, but a
cohort of MNR offspring were susceptible to impaired glucose tolerance with a higher
under the curve (AUCs) during the glucose tolerance test than any controls (10).
However, these changes are moderate and most evident after an insulin or glucose bolus
(10). Subsequently, the gene expression changes may be detectable after during
metabolic stress. Alternatively, impacts on transcription could be proportional to the
extent of maternal nutrient restriction. For example, transcription of genes involved in
regulation of epigenetics, circadian rhythms and lipid or glucose metabolism are altered
at weaning in offspring from 50% MNR throughout or late gestation to weaning (29,30).
These IUGR models are also in rats which have lower metabolic rates than mice (31). In
humans, basal metabolic rate is negatively correlated to insulin resistance (32) and could
suggest rats are more sensitive to disruptions in glucose homeostasis. Gene expression
changes in tissues could also decrease with age. Even with 50% MNR in rats, a low
number of genes and magnitude of effect are present in offspring at postnatal day 450
(30). It is also possible that gene expression changes occurred in tissues not assayed in
this study. One study showed that transcriptional responses to maternal protein restriction
was specific to each organ in the fetus (33).
Although transcription changes were limited in MNR offspring, liver had the most
differentially expressed genes. Two heat shock proteins (HSPs) were decreased in all
MNR and three in intolerant MNR. Small (Hspb2) and large (Hspa1a, Hsp1l, and
Hspa1b) HSPs act as chaperons and are induced during cellular stress. Reduced HSP
expression could indicate decreased cellular stress or a reduced response to similar stress
in MNR compared to controls. For example, increased ER stress occurs in rat offspring
from maternal protein restriction (34). Apart from the unfolded protein response, HSPs
mediate protein-protein interactions and function in prevention of apoptosis in mitophagy
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(35). Increased intracellular Hspa1a is associated with increased insulin sensitivity in
skeletal muscle but extracellular Hspa1a may decrease insulin sensitivity (36–38).
Depending on the cellular location, reduced Hspa1a expression in intolerant MNR could
have anti-inflammatory or proinflammatory effects, reducing or promoting insulin
sensitivity, respectively (36-38). HSPs also regulate cellular localization of transcription
factors such as the androgen receptor (39) and this pathway was not enriched in the
differentially expressed genes. Heat shock transcription factors (HSFs) regulate HSP
transcription but also are not differentially expressed (40,41). HSF activity can be
modulated via nuclear localization and post-translational modifications and were not
examined in this study (40,41). While it cannot be excluded that stress response deviates
in MNR and intolerant MNR through protein interaction with heat shock proteins, the
underlying cause of cellular stress was not implicated with the gene expression data.
Despite changes in genes regulating lipid metabolism, no differences were observed in
hepatic cholesterol or serum cholesterol and triglycerides in these adult MNR offspring
on standard chow (10). Offspring of maternal protein restriction in rats are more sensitive
to dietary-induced obesity and insulin resistance and have altered transcription of
cytochrome p450 gene family members (42). Altered expression of lipid metabolismrelated genes could indicate that MNR offspring are more sensitive to a high-caloric diet
in adulthood. However, the absence of dyslipidemia in standard chow-fed offspring
suggests genes regulating lipid metabolism are not likely the mechanism of glucose
intolerance in this study.
Few genes were differentially expressed in muscle and adipose tissue between maternal
nutrition or glucose tolerance groups. Differential gene expression in response to
maternal nutrition or growth restriction in fat pads and skeletal muscles have been
previously documented (43,44). It is possible that quadriceps femoris and perigonadal fat
pads are less sensitive to maternal nutrition than subcutaneous fat and biceps femoris
muscle that were used in previous studies (43,44). Maternal nutrient restriction may have
also had a greater impact on the tissues if it was reduced more than 30%. Although in
rats, even 50% MNR resulted in transcriptional changes in the fetal liver but not adipose
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tissue and skeletal muscle, suggesting the muscle and adipose tissue could be more
resistant to maternal diet (29). The absence of short and long-term impacts on gene
expression in adipose and skeletal muscle may relate to developmental timing. In rodents
and humans both of these tissues continue to develop into the postnatal period (45,46).
MNR offspring that had impaired glucose tolerance or higher fasting blood glucose levels
also have similar gene expression in the liver, fat and muscle compared to controls.
Similar expression suggests that fetal adaptations do not result transcriptome changes in
metabolic genes that persist into adulthood, at least in liver, skeletal muscle and adipose
tissue. Therefore, persistent gene expression changes are not likely the mechanism behind
the altered adult metabolism in this model of IUGR. Maternal diet or fetal growth
restriction can influence genomic stability, body mass composition, gut microbiome, and
transcription in other tissues such as the pancreas in offspring which could mediate long
term metabolism (47–50). Future studies are needed to identify alternate mechanisms
mediating effects of reduced maternal nutrition on susceptibility to aberrant glucose
metabolism in this model of growth restriction.
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Chapter 6 : Discussion
Summary and Prospective
MNR as a Model for Metabolic Changes Associated with
IUGR
We demonstrated in this study that moderate maternal nutrient restriction during
gestation in CD-1 mice resulted in fetal growth restriction and was associated with
changes in glucose metabolism of adult male offspring. Reduced fetal and liver size was
associated with increased hepatic transcription of genes in chronic hypoxia signalling. At
6-months, most male MNR offspring have increased hepatic insulin sensitivity and about
20% develop glucose intolerance. However, no changes in metabolically regulatory
transcripts were detected in 6-month adipose tissue, skeletal muscle and right medial liver
lobe. This suggested that in this model, fetal liver adaptations could be mediated by
transcription changes, but long-term alterations in glucose metabolism are not induced by
differential expression of metabolically regulatory genes in the liver, skeletal muscle and
adipose tissue.
The model can be used to study adaptations in response to pathological IUGR resulting
from fetal undernutrition in humans. Reduced nutrition is one adversity which is common
in placental insufficiency and maternal malnutrition (1). Clinically, IUGR is defined as a
pregnancy condition in which the estimated weight of the fetus is less than 10 percentile
th

expected for gestational age and an infant born from these pregnancies is termed small
for gestational age (SGA). However, infants can experience reduced nutrition, growth
restriction and metabolic adaptations, and have a birth weight greater than 10 percentile.
th

Clinically, these infants will not be identified as SGA, however, they are impacted
similarly to those who are SGA from IUGR pregnancies. Since long-term human studies
are challenging to conduct, we developed this model in mice to follow the offspring
within a feasible time frame (6 months) to conduct tissue-specific gene expression and
epigenetic studies. It was our expectation that the model of maternal nutrient restriction in
mice would allow investigations into molecular mechanisms that underlie long-term
morbidity in a number of tissues. In nutrient restriction models of IUGR, all offspring
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experience reduced nutrition during fetal life. Therefore, the model provides an
opportunity to investigate offspring that result in low birth weight as well as those who
do not. Immediate and long-term adaptations in response to fetal undernutrition would be
applicable to health outcomes of the newborns as well as in later life and include infants
encompassed and missed by the current clinical definition of IUGR.
Individuals born low birth weight, often used as a proxy for fetal growth restriction
(FGR) or intrauterine growth restriction (IUGR), are 1.4 times more likely to develop
type 2 diabetes as adults (2). Although at greater risk, not all of these infants will develop
type 2 diabetes. Results from this model indicate that maternal nutrient restricted
offspring with similar genetic backgrounds, maternal nutrition, and postnatal diet develop
variable glucose metabolism as adults. This model provides susceptible and nonsusceptible IUGR populations, which can be used to understand fetal adaptations that
may increase or decrease risk for adult glucose intolerance.
‘Catch-up’ growth, especially high growth rates in the first week of life in rodents (3,4)
or infancy/early childhood in humans (5), is associated with a more aberrant adult
metabolism; and prevention of early post-natal ‘catch-up’ is suggested to be
metabolically protective (4). Due to the rapid period of ‘catch-up’ growth in mice, it is
difficult to calculate growth rates between birth and day 3. While it is possible that
variations in catch-up growth could contribute to differences in susceptibility, it is
unlikely due to the short period of time in which it occurs.
Fetal implantation site may also contribute to degree of growth restriction in MNR
offspring. The main blood supply to the uterus is located at the periphery and at the
uterine horn (6). Fetuses implanted further away from the blood supply would have
experienced greater fetal undernutrition than pups closer to the blood supply. In our
study, no correlations between fetal weight at E18.5 and the site of implantation were
found. Subsequently, birth weight could not be used to estimate distance from the blood
supply but could contribute to variations within litters.
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CD-1 mice used in this model are an outbred strain and contain more genetic variability
relative to inbred strains. In humans, genetic polymorphisms such as a glycine to arginine
transition at codon 972 of IRS-1 are associated with insulin resistance and type II
diabetes (7). In mice, wild-type C57BL/6 develop diet-induced fatty liver but CD-1 do
not (8). However, strains produced from inbreeding CD-1 are susceptible to glucose
intolerance and obesity, indicating genes mediating adult metabolism exist in this
population (9). Such genetic variation likely contributes adult glucose metabolism in
response to fetal nutrition.
In both the fetal and the adult tissues studied, the liver was the most vulnerable to
alterations in maternal nutrition. When protein is reduced in maternal diet, fetal liver
weight is decreased relative to body weight (10). Small for gestational age infants also
have reduced liver weight compared to appropriate for gestational age infants (11). In this
model, both fetal and adult livers were reduced relative to body mass. Although not
measured in fetal livers, adult MNR offspring had increased insulin sensitivity. Insulin
signalling regulates pathways such as hepatic glucose output, glycogen synthesis and
mitogenesis, influencing glucose metabolism and hepatic growth. Additionally,
transcriptomic changes were most evident in the liver of adults relative to adipose tissue
and skeletal muscle, especially among the MNR that were glucose intolerant. Maternal
nutrient restriction in rats also resulted in hepatic transcriptional changes to epigenetic
machinery with minimal changes in skeletal muscle and adipose tissue (12). In agreement
with previous work, liver was sensitive to alterations in maternal nutrition, impacting
liver size, gene expression and metabolism.
Increased insulin sensitivity developed in response to fetal hypoinsulinemia in SGA
infants and growth restricted models and contribute to hypoglycemia early in life (13–
15). Increased insulin sensitivity promotes tissues such as the skeletal muscle to take up
and store glucose (14). This energy storage can cause rapid catch-up growth (13) which is
associated visceral adiposity in humans (16). Both ectopic lipid accumulation and
adiposity are risk factors for cardiometabolic disease (17). Unpublished work in our lab
measured serum insulin during GTT and serum blood glucose in E18.5 fetuses, and have
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demonstrated reduced insulin secretion and hypoglycemia also occur in the MNR fetus.
While increased sensitivity continues at 6 months in most MNR, relatively higher serum
insulin-to-glucagon ratios in intolerant MNR suggests that insulin resistance may have
developed in the susceptible population.

Interaction between Maternal Nutrition and Postnatal Diet
It is well known that overnutrition and poor dietary quality can result in obesity, insulin
resistance and glucose intolerance. Dietary and exercise intervention can be used to
prevent glucose intolerant populations from becoming type II diabetics (18). The timing
of obesity also influences risk for metabolic disorders. Obesity in children at puberty or
later had a positive association with type II diabetes (19). However, children that were
obese at age 7, but achieved and maintained a healthy body weight by puberty, had a
similar risk as the population that was not obese (19). Postnatal diets can enhance or
impair detrimental effects in offspring from maternal nutritional insults. Specifically,
continued calorie restriction after birth can prevent aberrant metabolic outcomes, and
overnutrition or poor dietary quality can exaggerate the maladaptive impacts of fetal
undernutrition on adult metabolism (20). This is thought to occur because the fetus adapts
to a nutrient restrictive environment, and when postnatal food is abundant adaptations
promoting energy conservation rather than expenditure are no longer an advantage.
Contrary to other models of growth restriction demonstrating increased susceptibility to
diet-induced obesity and metabolic disorders, a HFHS post-weaning diet did not result in
a difference between control and MNR offspring in the metabolic parameters measured.
Often these diets are high-fat rather than high-fat high-sugar (3). HFD and growth
restriction in rats impaired beta cell survival independently (21). When HFD and growth
restriction were combined, islet damage was not cumulatively worse, suggesting that
growth restriction and calorie dense diets could converge on similar mechanisms (21).
Additionally, although some controversy exists on whether high-sugar or high-fat diets
are more detrimental, most studies agree that excess calories is one of the main factors
contributing to metabolic health. In this study, mice on the HFHS diet ate less food (in
grams) and resulted in a similar calorie intake as standard chow-fed offspring. Similar to
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our study, male, but not female, rat offspring from maternal protein restriction on a HFD
ate less (in grams), resulting in an isocaloric diet (22). While this dietary challenge did
not vary based on maternal nutrition, all offspring developed and a reduced glucose
tolerance and increased body weights. These data indicate an importance in dietary
quality in determining adult metabolism. It is possible that a high-fat diet or high caloric
diet would have different impacts on control and MNR adult glucose metabolism.
However, isocaloric high-fat high-sugar post-weaning diet did not increase MNR
susceptibility to metabolic disorders relative to controls.

Gene Expression Changes in Offspring Associated with
Maternal Nutrition and Adult Glucose Metabolism
In this study, gene expression was analyzed by three common differential expression
tools, DESeq2, EdgeR and Aldex2, that perform well in synthetic and real RNAseq data
sets (23,24). Genes were considered differentially expressed if they were detected by two
or more tools. This approach was taken because no ‘gold standard’ for differential gene
expression exists. In all three tools, counts are normalized or transformed to control for
differences in library size and composition. Following normalization or transformation,
the counts were fitted to a model and statistical comparisons between groups and multiple
testing corrections were done. However, each program uses different approaches for
these steps (Table 6.1.1). Quin et al. (2018), recently compared the precision
(minimizing false positives) and recall (true positives) between all three software (24).
The authors found Aldex2 had high precision but low recall for studies with < 10
samples, and that EdgeR and DESeq2 have more sensitivity for this range of replicates
(24). Although their study used the Wilcox Rank test in Aldex2 which would have lower
power than the Welch’s test used in this study for few replicates (25). Still, with 7-9
replicates per group few differentially expressed genes were detected by Aldex2 likely
due to the limited statistical power of the non-parametric test. Focusing on genes that
were differentially expressed in multiple tools may address the reproducibility issues
found with RNA sequencing studies, and was the approach taken in this study.
To identify genes associated with fetal adaptations and adult metabolism, the
transcriptome of liver, skeletal muscle and adipose tissue in adult mice and fetal liver
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were analyzed. Genes that were differentially expressed, particularly those changed in
both the fetus and the adult, could be mediate fetal adaptations and maladaptive changes
that influence adult glucose metabolism. Because changes in glucose metabolism were
only detected in standard chow-fed adult offspring, adult expression was only examined
on this diet.
In the liver of MNR fetuses, differentially expressed genes were involved in overlapping
regulation of various transcription factors (Figure 6.1.1). However, hypoxia-induced
signalling was the primary pathway with changes up- and down-stream of the
transcription factors. Additionally, with moderate fold change in transcription and
significant enrichment with multiple pathway enrichment tools, we focused on the
cumulative change in HIF signalling.
Growth restriction caused by reduced maternal nutrition and maternal hypoxia result in
similar fetal and placental adaptations. Increased placental size, more efficient
vasculature, and no changes in placental hypoxia, suggest that both hypoxic and nutrient
restricted placentas are able to compensate (29–31). Despite placental adaptations,
hypoxia and MNR cause fetal circulation to redistribute oxygenated blood from the
umbilical cord away from the liver and to the brain (32,33). In growth restricted humans,
blood flow from the umbilical cord is reduced to both liver lobes, but the reduction is
greater to the right and is the portion of the liver examined in this study (34).
Additionally, glucose deprivation in colon cancer cell lines can induce hypoxia signalling
(35,36), suggesting fetal nutrient availability may also be modulating HIF signalling in
MNR offspring. Increased HIF-2a and HIF-3a transcripts and protein, and increased
transcription of HRE-containing genes in this study support evidence of hypoxia
signalling in MNR fetal liver. Further studies need to be done to understand whether
redistribution of fetal circulation and/or nutritional regulation cause the induction of
hypoxia-inducible signaling in response to maternal nutrition. Regardless of the
mechanism, maternal hypoxia and MNR could induced the HIF pathway in the right
lobes of the liver and contribute to similar adaptations in offspring.
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Hypoxia signalling is involved in the regulation of metabolism, pluripotency and
differentiation of progenitor cell populations and angiogenesis (37,38), which are
important pathways tightly regulated in tissue development. Increased HIF-2a and HIF3a are associated with chronic hypoxia and the switch from HIF-1a to HIF-2a occurs in
developing tissue when vascularity and oxygen tension increase (39,40). Tissue sampling
late in gestation, when the HIF-1a to HIF-2a switch may have occurred, likely contribute
to the detection of HIF-2a but not HIF-1a. Additionally, the prolonged exposure of the
fetus to nutrient restriction in this model could result in chronic hypoxia signalling and
mediate an increase in HIF-2a and HIF-3a protein.
HIF-1a transcriptional targets were initially thought to be involved in promoting
glycolytic metabolism and HIF-2a targets in fatty acid oxidation and matrix remodeling.
(41,42). Both HIF-1a and HIF-2a regulate angiogenesis(42). Gene expression in
neuroblastoma cells exposed to acute hypoxia and to chronic or moderate hypoxia were
similar suggesting that the number of HIF redundant targets may be less than initially
cited, and that conflicting evidence might be confounded by the temporal regulation of
HIF-1a or HIF-2a (39). Additionally, Kdm3a, Ccng2, Hif-3a and Pfkfb3 were induced
with both HIF-2a and HIF-1a overexpression in human umbilical vein endothelial cells
(42). Subsequently, hypoxia inducible genes were not sorted based on HIF-1a or HIF-2a
targets in the literature.
HIF-dependent hypoxia inducible transcripts increased in MNR were involved in
metabolic (PFKFB3, FKBP5) and direct (KDM3a) or indirect (FKBP5) epigenetic
responses. Enhanced expression of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase
3 (PFKFB3) promotes glycolysis and could influence hepatic glycogen (43). FKBP5 is
associated with insulin resistance through inhibition of glucocorticoid signalling and as a
co-chaperone to the Akt phosphatse, PHLPP(44,45). Both glucocorticoids and insulin
promote glycogen deposition in the liver (46). While transcript levels were increased,
protein changes were not significant suggesting these adaptations were not sufficient in
preventing glycogen depletion during MNR fetal hypoglycemia. Near birth fetal
metabolism in the liver shifts from glycolytic to gluconeogenic which may also indicate a
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delay in this shift in MNR male offspring (47). Reduced liver size, increased hypoxia
signaling, as well an increased marker of proliferation and reduced glycogen identified in
this model, suggests that MNR have immature livers at E18.5.
Differential expression of genes involved in the regulation of epigenetic machinery
provide a mechanism for long-term impacts of fetal undernutrition. In neural cells,
FKFBP5 increase is negatively associated with global methylation by competitively
inhibiting FKBP52 recruitment and reducing DNTM1 efficiency (48). KDM3a is a
histone methyl transferase which removes mono and di-methylation at histone 3 lysine 9,
typically associated with heterochromatin, especially at HRE-containing genes(49).
Increased transcription of both modifiers could suggest epigenetic changes are
influencing fetal transcription at HRE and non-HRE-containing genes and require further
studies.
Although increased transcription of genes induced by HIFs were detected, the increase
was moderate and not significantly reflected at the protein level. HIF-3a has been shown
to weakly induce some HRE-containing genes, but most functional evidence suggests a
role in repression of HIF-1/2a-dependent transcription (50,51). Increased HIF-3a might
be repressing the transcriptional activity of HIF-2a and the magnitude of hypoxia
response in MNR offspring. In MNR in guinea pigs, increased hepatic EPO protein were
only significantly different in females suggesting that female fetuses may adapt with
increased erythropoiesis (30). Although females were not examined in this study, it is
possible that the hypoxic response in males is more moderate and could be mediated
through HIF-3a.
Hypoxic gene expression changes were not detectable in MNR adult livers. In fact, few
transcriptional changes were detected in liver, skeletal muscle and adipose tissue.
Maternal nutrient restriction in rats resulted in alterations in fetal epigenetic machinery
but histone acetylation changes did not persist to 4 weeks (12). Additionally, the number
of genes impacted was reduced over time, despite metabolic changes becoming more
evident with age (52). However, if fetal undernutrition during pregnancy established
differences in cell populations and/or differences in how the cells are functioning,

117

changes in gene expression would be expected. Consequently, although these adaptations
may occur, they do not persist and are not likely the mechanism underlying changes in
glucose metabolism in this model.
It should be noted most changes in glucose metabolism were only detected in stress
conditions, such as glucose tolerance and insulin challenge tests. Fetal hepatic changes
were detected when the stress of nutrient restriction was still evident and altered HIF
signaling might be evident in MNR offspring during a glucose or insulin challenge. In
chronic myeloid leukemia patients, VHL loss-of-function mutations result in changes to
methylation at HRE-promoters but do not result in increased HIF signaling until a
‘second hit’ occurs (53). The differential priming of HRE-genes in these individuals
increase anti-apoptotic and angiogenic responses in the tumor (53). While differences in
VHL were not confirmed in the validation cohort, KDM3a and FKBP5 were increased. It
cannot be excluded that the transcription during stressed conditions could vary in HIF or
other stress response pathways in tissues of MNR adult offspring.
Intrauterine fetal adaptations to moderate nutrition restriction could also be independent
of changes in cell populations or persistent epigenetic changes. Evidence of altered gut
microbiome and reduced genomic stability have been observed in response to different
maternal diets (54,55). Protein function and stability can also be regulated by genetic
polymorphisms and miRNAs. Lastly, tissues not yet examined in this model could have
influenced fetal adaptations and modulated susceptibility in the MNR population.
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Table 6.1.1 Comparison of tools used for differential expression
Tool

DESeq2

EdgeR

Aldex2

Normalization/
Transformation

•

Normalize with a
scaling factor

•

Median of ratios to
the geometric
mean

•

Normalized with a
scaling factor

•

Weighted mean of
ratios in a pairwise
comparison of
each sample and a
reference sample
•

Transformed by
the centered log
ratio (clr)

Statistical analysis

Model of
Count
Means
Negative
binomial

Multiple
comparisons
adjustments
BenjaminiHochberg
correction

Empirical Bayes
estimation of
dispersion and an
adapted Fisher’s
exact test
(parametric)

Negative
binomial

Empirical Bayes to
estimate Monte
Carlo Dirichlet
instances and
Welch’s test (nonparametric)

Poisson
distribution

Empirical Bayes
estimation of
dispersion and log
fold change for the
Wald test
(parametric)

Outlier
Detection

Reference

Cooks
Distance
(>99th
percentile)
for ³ 7
samples

(26)

BenjaminiHochberg
correction

None

(27)

BenjaminiHochberg
correction

None

(25,28)
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Figure 6.1.1 Genes differentially expressed up- and down-stream of transcription
factors in fetal hepatic liver.
Differential expression was detected upstream from many transcription factors (indicated
by the grey bar) important in tissue development and metabolism. However, genes
involved in hypoxia-inducible factor signalling were differentially regulated up- and
downstream from HIF transcription factors.
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Limitations and Future Studies
This the first in-depth use of maternal nutrient restriction post-implantation to birth in
CD-1 mice to study the association between reduced fetal nutrition and long-term
metabolic outcomes. While metabolic and expression changes identified in this study
provide insight for understanding the relationship between maternal nutrition and fetal
adaptations, there are also associated limitations that can be addressed with further
studies.

Further Characterization of Metabolic and Expression
Outcomes in MNR Offspring
Increased PAI-1 and resistin in MNR serum could indicate increased fat mass or metainflammation. However, mRNA of PAI-1 and resistin were not different in MNR adipose
tissue compared to controls. Transcripts in inflammatory pathways were also similar in
control and MNR adipose tissue, suggesting increased fat mass rather than adipocyte
meta-inflammation in MNR offspring. Reduced lean mass been associated with other
models of MNR and can contribute to decreased glucose tolerance (56). In animal
studies, the ‘gold method’ is via chemical carcass analysis which is terminal and requires
the entire carcass (57). Micro-CT imaging is accessible to our lab, can be done on live
specimens, distinguishes between subcutaneous and visceral adipose tissue, and provide
accurate estimate of body mass composition in mice (58,59). Utilizing this technology in
adult offspring would determine whether body mass composition is different in MNR
offspring and allow metabolic and expression analysis in the same mouse.
Insulin sensitivity was only measured in a portion of the cohort due to technical
limitations in the hepatic portal vein insulin challenge. The most accurate and sensitive
method for tissue-specific and whole-body insulin sensitivity is hyperinsulinemic
euglycemic clamp studies. While this method can be performed on a large sample
number, it is technically challenging, requires expensive equipment, and is difficult to
analyze. If the equipment or expertise were available, this technique could be used.
Alternatively, injection of insulin or saline and collecting tissues could be done in all
animal of a cohort after 6-month glucose tolerance testing. Similar to the gene expression
analysis in this study, tolerant, intolerant and average controls could be used to detect
pAKT to AKT ratios. While the sample size per group would not increase with this
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design, tissue-specific insulin sensitivity could be quantified for intolerant MNR relative
to control and tolerant MNR populations.
During the insulin challenge test or hyperinsulinemic euglycemic clamp study, liver,
adipose tissue and skeletal muscle could also be collected for gene expression analysis.
Studies in humans show that hyperglycemia and hyperinsulinemia initiate gene
expression changes in many tissues (60,61). Additionally, insulin-induced gene
expression in the skeletal muscle and adipose tissues during hyperinsulinemic clamp
studies were blunted in type 2 diabetics compared to controls, despite having similar
basal expression (60). To our knowledge, gene expression in adult offspring from growth
restricted models have not been examined after a glucose or insulin bolus. This would
assess whether adaptations are present in MNR offspring in metabolic ‘stress’ conditions.

Influence of Reduced Nutrition in Gestation and
Throughout Lactation of Skeletal Muscle and Adipose
Tissue
In addition to examining changes in gene expression during hyperinsulinemia, extending
nutrient restriction until weaning could also influence long term impacts. With the current
model, skeletal muscle and adipose tissue had few differentially expressed genes. In mice
the number of muscle fibers is determined around day 7 and the number of myonuclei by
day 21 (62). Establishment of white adipose tissue occurs in two phases, the first from
birth to two weeks of life and the second in puberty (around weaning) (63). Although
hyperplasia and hypertrophy of white adipose tissue continue throughout life, the rate of
increase is steady through adulthood (63). The offspring in this study were fostered to ad
libitum-fed mothers, receiving ad libitum for the postnatal developmental periods.
Extension of nutrient restriction throughout lactation would provide further insight into
the effects of reduced nutrition on development of these tissues. However, it may also
modify ‘catch-up’ growth and adult metabolism (64). Extending nutrient restriction to
weaning would assess the interaction between MNR and nutrition during lactation and
could increase impacts on skeletal muscle and adipose tissue.
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Mechanism of Fetal Hepatic Hypoxia in Adaptations to
Growth Restriction
The concept of hypoxia signalling in growth restricted infants is relatively new. Dynamic
changes to hypoxic signalling suggest that the impact at different developmental stages
could vary (37,65). Temporal analysis of hepatic HIF-1a, HIF-2a, and HIF-3a mRNA
and protein during liver development in control and MNR offspring is needed. This study
would determine if a switch from HIF-1a to HIF-2a occurs in the liver and whether the
peak expression or stabilization vary between control and MNR. RNAseq at peak
expression could provide insight into the changes mediated by altered HIF signalling in
the MNR offspring.
In addition to understanding the timing of HIF signalling, further experiments need to
determine how increased hepatic hypoxia influences fetal adaptations to nutrient
restriction. Knocking down and overexpressing fetal hepatic HIF-2a and HIF-3a, and
HIF-1a if MNR influences protein levels earlier in gestation, during MNR would clarify
whether increased HIF signalling is an advantage for fetal survival. Recombinant adenoassociated virus (rAAV) injected into the amniotic sac with miRNA or expression vectors
under the control of the alpha fetoprotein promoter would allow for such liver-specific
fetal gene manipulation (66,67). Since differentially expressed genes in the fetus did not
persistent into adult life, temporal knock down or overexpression is preferable. These
studies would gain insight into the role of HIFs in liver development and fetal survival
during undernutrition. It would also determine whether these adaptations mediate long
term metabolic outcomes of the MNR offspring.

Overall Conclusions and Significance
This study investigated fetal and adult adaptations in liver, adipose tissue and skeletal
muscle of maternal nutrient restricted male offspring in mice on a post-weaning standard
chow or a HFHS diet (Figure 6.3.2). Offspring from MNR pregnancies experienced fetal
growth restriction and changes to adult glucose tolerance or insulin signalling. In the
fetus, reductions in maternal calories disproportionately impacted the liver and might be
mediated through increased hypoxia signalling. Differences in hypoxia-inducible
transcripts did not persist to 6 months. As adults, minimal changes in gene expression in
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all three tissues were detected. However, the liver of MNR offspring was smaller with
increased insulin sensitivity. As adults, MNR was associated with increased serum
peptide markers that suggest changes to body mass composition. Despite the changes in
standard chow-fed offspring, no differences between MNR and controls on an isocaloric
post-weaning HFHS diet were detected. While liver weight, insulin sensitivity and
potentially body mass composition are influenced by MNR, post-weaning diet overcame
maternal nutrient effects.
To our knowledge this is the first study of growth restriction where susceptible and nonsusceptible populations are examined in addition to changes occurring in all offspring.
Despite having susceptible and non-susceptible adult populations in standard chow-fed
offspring, metabolic and gene expression changes were only moderately impacted. Gene
expression during metabolic stress could provide insight into variability in the MNR
offspring. Additionally, serum peptide markers suggest body mass composition and
appetite could be influencing susceptibility. Despite fetal liver adaptations and adult
metabolic changes gene expression changes in metabolically regulatory genes were not
differentially expressed.
Understanding tissue-specific adaptations from reduced fetal nutrition and how they
mediate adult glucose intolerance will provide insight into the increased risk for type 2
diabetes in human growth restricted populations. Type 2 diabetes has significant
complications and causes a substantial financial burden on the medical system (68). Early
identification and prevention can reduce cost and improve patient quality of life.
Identifying such adaptations will aid in recognizing, preventing and/or treating aberrant
glucose metabolism in these individuals. Additionally, this study supports the notion that
fetal nutrition is important in establishing adult liver metabolism which could impact
chronic diseases beyond metabolic disorders.
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Figure 6.3.1 Metabolic and expression changes in the male fetal and adult offspring
from maternal nutrient restriction.
In the fetus, body and liver weight is reduced (chapter 2) and transcripts in HIF signalling
were induced (chapter 4). On standard chow, MNR offspring had increased hepatic
insulin sensitivity, reduced liver weight and increased serum markers for adiposity
relative to controls (chapter 2). 20% of the MNR offspring were susceptible to glucose
intolerance (chapter 2) and had increased differentially expressed (DE) genes (chapter 5).
Post-weaning HFHS diet did not differentially impact MNR and control offspring in the
parameters measured in this study (chapter 3).
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Supplementary Figure S2.3.1. Fetal weight relative to distance from the uterine
blood supply. Pups at position 1 are closest to the ovaries or cervix in the uterine horn.
Control (green) and MNR (red) litters are represented by different shades. Weight did not
significantly differ between according to position (p = 0.4).
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Supplementary Figure S2.3.2 Pyruvate challenge tests in male MNR and control
offspring at 6 month of age. (a) There were no significant differences in blood glucose
from 0 to 120 min (p = 0.4). (b) Similar total AUC between control and MNR indicate no
differences in hepatic glucose output (p = 0.3). Control N=5, MNR N=5 (1 pup/litter).
Data are mean ± SEM (a). Asterisk represents a p < 0.05 with a repeated measures
ANOVA (a) or unpaired t-test (b).
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Supplementary Table 2.2.1. Litter sizes and sex ratios for litters included in pre- and
postnatal studies.
Study Type

Fetal

Postnatal

Maternal Nutrition

Fraction of Males

Litter Size

Control
Control
Control
Average
MNR
MNR
MNR
Average
Control
Control
Control
Control
Control
Average
MNR
MNR
MNR
MNR
MNR
MNR
MNR
MNR
MNR
MNR
Average

0.42
0.57
0.62
0.54 +/- 0.06
0.57
0.5
0.27
0.45 +/- 0.09
0.46
0.67
0.79
0.54
0.54
0.6 +/-0.06
0.55
0.45
0.38
0.46
0.69
0.62
0.5
0.3
0.38
0.75
0.51 +/- 0.46

14
14
13
13.7 +/- 0.3
14
12
11
12.33 +/- 0.8
15
12
14
13
13
13.4 +/- 0.5
11
11
13
13
13
13
12
13
13
12
12.4 +/- 0.3

Note: No significant differences between control and MNR were observed with an
unpaired t-test. Mean is expressed as +/- SEM.
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Supplementary Figure S4.3.3 HIF-1a protein in mouse fetal (E18.5) liver and
placenta, and normoxic and hypoxic HeLa cells.
HIF-1a was detected in the placenta and HeLa cells but was not detected in the liver.
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Supplementary Table 4.3.1 Top 50 pathways arranged by fold change (FC) of genes
in distribution 2 on principle component 1 enriched in GO pathways (FDR < 0.05).
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50

GO pathway

FC

regulation of response to nutrient levels (GO:0032107)
regulation of response to extracellular stimulus (GO:0032104)
zymogen activation (GO:0031638)
hippocampus development (GO:0021766)
limbic system development (GO:0021761)
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)
potassium ion transmembrane transport (GO:0071805)
cellular potassium ion transport (GO:0071804)
positive regulation of epithelial cell proliferation (GO:0050679)
visual perception (GO:0007601)
sensory perception of light stimulus (GO:0050953)
regulation of blood pressure (GO:0008217)
second-messenger-mediated signaling (GO:0019932)
regulation of epithelial cell proliferation (GO:0050678)
regulation of anatomical structure size (GO:0090066)
positive regulation of response to external stimulus (GO:0032103)
positive regulation of cellular component biogenesis (GO:0044089)
inorganic cation transmembrane transport (GO:0098662)
response to growth factor (GO:0070848)
cellular response to growth factor stimulus (GO:0071363)
cell-cell adhesion (GO:0098609)
cation transmembrane transport (GO:0098655)
axon development (GO:0061564)
regulation of cellular component size (GO:0032535)
inorganic ion transmembrane transport (GO:0098660)
forebrain development (GO:0030900)
metal ion transport (GO:0030001)
negative regulation of cell development (GO:0010721)
regulation of ion transmembrane transport (GO:0034765)
positive regulation of nervous system development (GO:0051962)
regulation of ion transport (GO:0043269)
positive regulation of neuron differentiation (GO:0045666)
regulation of metal ion transport (GO:0010959)
regulation of neuron differentiation (GO:0045664)
positive regulation of cell proliferation (GO:0008284)
muscle structure development (GO:0061061)
positive regulation of MAPK cascade (GO:0043410)
regulation of nervous system development (GO:0051960)
calcium ion homeostasis (GO:0055074)
negative regulation of cell proliferation (GO:0008285)
regulation of cellular component biogenesis (GO:0044087)
negative regulation of cell differentiation (GO:0045596)
divalent inorganic cation homeostasis (GO:0072507)
regulation of cell cycle process (GO:0010564)
regulation of cell cycle (GO:0051726)
cell proliferation (GO:0008283)
regulation of MAPK cascade (GO:0043408)
regulation of cell proliferation (GO:0042127)
positive regulation of secretion (GO:0051047)

3.59
3.59
2.59
2.29
2.22
2.14
1.94
1.93
1.93
1.88
1.88
1.87
1.73
1.63
1.62
1.58
1.57
1.56
1.55
1.55
1.53
1.53
1.53
1.53
1.53
1.53
1.52
1.52
1.51
1.5
1.5
1.49
1.49
1.48
1.46
1.46
1.46
1.46
1.46
1.45
1.44
1.44
1.44
1.44
1.44
1.43
1.43
1.43
1.43
1.43

FDR
1.93E-02
1.92E-02
2.77E-02
3.29E-02
1.28E-02
1.43E-02
6.25E-03
2.45E-02
2.44E-02
4.85E-03
3.13E-02
3.41E-02
3.39E-02
1.70E-02
6.38E-03
3.58E-04
4.93E-02
1.40E-03
1.24E-02
1.21E-02
2.13E-02
2.83E-02
1.22E-02
3.97E-02
1.97E-02
1.20E-02
3.26E-02
3.57E-03
3.95E-02
1.33E-02
1.79E-03
5.61E-04
2.09E-02
4.88E-02
9.11E-04
6.76E-05
2.83E-02
1.49E-02
4.91E-05
4.34E-02
4.43E-03
3.31E-04
2.67E-03
4.91E-02
1.46E-02
3.07E-04
1.65E-02
3.32E-03
1.39E-07
3.87E-02
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Supplementary Table 4.3.2 Counts and cluster membership per sample (k-means
clustering, K=2)
Condition
Cluster
Counts
MNR
2
74305030
Control
2
75865086
Control
2
80360976
MNR
2
80920037
Control
2
81553460
MNR
2
83508564
Control
2
83775128
MNR
2
84106928
MNR
2
84462329
MNR
2
85525474
Control
2
86281726
MNR
2
87068555
Control
1
92585570
MNR
1
98375605
Control
1
99626219
Control
1
105476459
MNR
1
105755590
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Supplementary Table 4.3.3 49 protein-coding genes differentially expressed in MNR
E18.5 liver relative to controls (FDR < 0.1 in 2 or more tools).
Gene
Symbol
1

Lin28a

2

Rnf169

3

Chrna4

4

Angptl4

5

Cited2

6

Ppargc1b

7

Echdc1

8

Kbtbd8

9

Atp2b2

10

Cars

11

Wisp2

12

Mll1

13

Ppp1r15a

14
15

Capn10
Man2b2

16

Syne1

17

Rassf1

18

Coro7

19

Kdm3a

20

Chd7

21
22
23

Mycbp2
Crls1
Cep170

Gene Name
lin-28 homolog A (C.
elegans)
ring finger protein 169
cholinergic receptor,
nicotinic, alpha
polypeptide 4
angiopoietin-like 4
Cbp/p300-interacting
transactivator, with
Glu/Asp-rich carboxyterminal domain, 2
peroxisome proliferative
activated receptor,
gamma, coactivator 1
beta
enoyl Coenzyme A
hydratase domain
containing 1
kelch repeat and BTB
(POZ) domain
containing 8
ATPase, Ca++
transporting, plasma
membrane 2
cysteinyl-tRNA
synthetase
WNT1 inducible
signalling pathway
protein 2
myeloid/lymphoid or
mixed-lineage leukemia
1
protein phosphatase 1,
regulatory (inhibitor)
subunit 15A
calpain 10
mannosidase 2, alpha B2
synaptic nuclear
envelope 1
Ras association
(RalGDS/AF-6) domain
family member 1
coronin 7
lysine (K)-specific
demethylase 3A
chromodomain helicase
DNA binding protein 7
MYC binding protein 2
cardiolipin synthase 1
centrosomal protein 170

DESeq2
FC
FDR

EdgeR
FC
FDR

Aldex2
FC
FDR

-1.92

0.00

-6.03

0.00

NA

NA

-1.78

0.00

-9.51

0.00

NA

NA

-1.61

0.00

-2.28

0.01

NA

NA

-1.59

0.00

-2.49

0.01

NA

NA

-1.52

0.00

-1.74

0.03

NA

NA

-1.50

0.02

-2.47

0.07

NA

NA

-1.46

0.00

-1.49

0.00

NA

NA

-1.37

0.01

-1.45

0.07

NA

NA

-1.31

0.00

-1.36

0.01

NA

NA

-1.29

0.03

-1.34

0.08

NA

NA

-1.28

0.03

-1353.64

0.00

NA

NA

1.15

0.00

1.15

0.10

NA

NA

1.17

0.06

1.18

0.09

NA

NA

1.19
1.19

0.00
0.00

1.19
1.19

0.08
0.08

NA
NA

NA
NA

1.19

0.00

1.20

0.00

NA

NA

1.22

0.01

1.23

0.05

NA

NA

1.22

0.00

1.22

0.08

NA

NA

1.22

0.00

1.23

0.08

NA

NA

1.23

0.01

1.24

0.03

NA

NA

1.23
1.23
1.26

0.00
0.00
0.00

1.23
1.24
1.27

0.00
0.08
0.06

NA
NA
NA

NA
NA
NA
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24

Maff

25

Stard5

26

Rabgef1

27

Hif3a

28

Pex26

29

Vhl

30

Inpp4a

31

Lpin1

32

Kif21a

33

Hpca

34

Fam126b

35

Nlrp12

36

Sra1

37
38

Cd80
Gata4

39

Jmy

40

Trpv4

41
42

Ccng2
Cobll1

43

Pfkfb3

44

Tiparp

45

Fkbp5

46

Josd1

47

Btg2

48

Tubb2a

49

Fbxo31

v-maf
musculoaponeurotic
fibrosarcoma oncogene
family, protein F (avian)
StAR-related lipid
transfer (START)
domain containing 5
RAB guanine nucleotide
exchange factor (GEF) 1
hypoxia inducible factor
3, alpha subunit
peroxisomal biogenesis
factor 26
von Hippel-Lindau
tumor suppressor
inositol polyphosphate4-phosphatase, type I
lipin 1
kinesin family member
21A
hippocalcin
family with sequence
similarity 126, member
B
NLR family, pyrin
domain containing 12
steroid receptor RNA
activator 1
CD80 antigen
GATA binding protein 4
junction-mediating and
regulatory protein
transient receptor
potential cation channel,
subfamily V, member 4
cyclin G2
Cobl-like 1
6-phosphofructo-2kinase/fructose-2,6biphosphatase 3
TCDD-inducible
poly(ADP-ribose)
polymerase
FK506 binding protein 5
Josephin domain
containing 1
B cell translocation gene
2, anti-proliferative
tubulin, beta 2A class
IIA
F-box protein 31

1.26

0.02

1.28

0.10

NA

NA

1.28

0.00

1.29

0.02

NA

NA

1.28

0.00

1.29

0.00

NA

NA

1.29

0.01

1.32

0.03

NA

NA

1.31

0.01

1.35

0.10

NA

NA

1.32

0.03

1.39

0.10

NA

NA

1.33

0.00

1.36

0.00

NA

NA

1.35

0.02

1.44

0.09

NA

NA

1.36

0.00

1.40

0.02

NA

NA

1.37

0.01

1.44

0.03

NA

NA

1.37

0.01

1.46

0.04

NA

NA

1.40

0.00

1.50

0.03

NA

NA

1.42

0.00

1.52

0.02

NA

NA

1.45
1.45

0.02
0.01

1.69
1.63

0.08
0.03

NA
NA

NA
NA

1.47

0.00

1.52

0.00

NA

NA

1.48

0.01

1.70

0.03

NA

NA

1.50
1.51

0.00
0.00

1.62
1.57

0.00
0.00

NA
NA

NA
NA

1.53

0.00

1.61

0.00

NA

NA

1.53

0.00

1.71

0.01

NA

NA

1.56

0.00

1.82

0.01

NA

NA

1.64

0.00

NA

NA

2.03

0.10

1.64

0.00

NA

NA

2.16

0.06

1.69

0.00

2.35

0.01

NA

NA

1.75

0.00

NA

NA

1.98

0.08
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Note: Fold change (FC) discussed was taken from the DESeq2 analysis which was the
most conservative. False discovery rate (FDR) was calculated with a BenjaminiHochberg correction.
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Supplementary Table 4.3.4 Function of hypoxia-inducible genes differentially
expressed in MNR offspring.
Gene Symbol
Vhl
Mll1
Chrna4
Rassf1
Jmy
Nrp12
CD80
Ccng2

Maff
Angptl4
Btg2
Fkbp5
Pfkfb3
Kdm3a

Hif-3a

Ppp1r15a
Cited2

Role in HIF signalling
Negative regulator of Hif-1a and
Hif-2a
Transcriptional co-activator at
HRE-containing genes
Neuronal acetylcholine receptors
promote accumulation and
stability of Hif-1a
Upregulated with hypoxia and
HIF1/2a expression
Hypoxia-induced HREcontaining gene
Transcriptionally downregulated
by HIF-1a
Reduction on myeloid cells in
response to hypoxia
Hypoxia-induced HREcontaining gene
Hypoxia-induced HREcontaining gene
Hypoxia-induced HREcontaining gene
Hypoxia-induced Hif-1a
dependent transcription
Hypoxia-induced gene
potentially via HIF-2a inhibition
of AR, and as a KDM3a target
Hypoxia-induced HREcontaining gene
Hypoxia-induced HREcontaining gene and is recruited
to promoters of HRE-containing
genes
Induced by HIF-1a and a
negative regulator of HIFinduced transcription
Hypoxia-induced HREcontaining gene
Prevents CBP/P300 binding
inhibiting HIF-1a transactivation

Functions
U3 ubiquitin ligase complex

References
(1)

H3K4 Histone demethyltransferase

(2)

Nicotine receptor

(3)

Tumor suppressor

(4,5)

Actin polymerization

(6)

Receptor, ligands include VEGF

(7)

Stimulates T-cell innate immunity

(8)

Negative cell cycle
regulation/regulation of the
cytoskeleton
Transcriptional regulator

(9,10)

Secreted protein involved in
angiogenesis and is a negative
regulator of lipoprotein lipase
Negative cell cycle regulation

(12–14)

Co-chaperon and scaffold protein

(5,16,17)

Phosphatase and diphosphatase to
fructose-2,6-bisphosphotate
H3K9 histone demethylase

(5,18)

Transcriptional regulator

(19,20)

Unfolded protein response reducing
protein synthesis
Transcriptional regulator

(5,21)

(5,11)

(15)

(5,14)

(22)
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Appendix 3
Chapter 5 Supplementary Figures

Supplementary Figure S5.2.1 Biplots of controls (A), intolerant MNR (B) and
tolerant MNR (C) in liver RNAseq data.
One sample in the tolerant MNR (red box) contributed more variation to the group than
any other samples and was removed from further analysis.
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Supplementary Figure S5.2.2 Biplots of controls (A), intolerant MNR (B) and
tolerant MNR (C) muscle RNA sequencing data.
One control and one intolerant MNR (red box) contributed more variation to the group
than any other samples with the group. Outliers were removed from further analysis.
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Supplementary Figure S5.2.3 Biplots of sequenced RNA from adipose tissue of
controls (A), intolerant MNR (B) and tolerant MNR (C).
One sample from each group (red box) contributed more variation to the group than any
other samples with the group and were removed from further analysis.
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Supplementary Figure S5.2.4 Fasting blood glucose of 6-month-old control and
MNR offspring.
Fasting blood glucose was similar for control (6.5 ± 0.3 mmol/L) and MNR (7.3 ± 0.3
mmol/L) offspring (p = 0.2), however, 4 MNR had a higher fasting blood glucose than
any controls (as indicate by the box). Data are expressed as mean ± SEM and compared
with a Mann-Whitney test.
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Supplementary Figure S5.3.1 PCA of top 500 variable genes in RNAseq data of the
liver, adipose tissue, and skeletal muscle of 6-month-old MNR offspring. Samples
clustered based on tissue (colour) but not maternal nutrition (symbol).
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Supplementary Table 5.3.1 Differentially expressed genes (0.1 >FDR, Fold change
[FC] ³ 2, 2 or more tools) in liver, skeletal muscle and adipose tissue of 6-month-old
offspring.
Tissue

Reference

Liver

Control

Comparison
Group
MNR

Gene ID
Alas1

Hspa1l

Hspb1

Fgf11

Rfx4

Trem2

Control

Intolerant
MNR

Hspa1a
Hspa1l
Alas1
Hspa1b
Dnaic1

Hspb1
Eif4ebp3

Saa1
Grem2

Pcp4l1

Gene Name
aminolevulinic acid synthase
1 [Source:MGI
Symbol;Acc:MGI:87989]
heat shock protein 1-like
[Source:MGI
Symbol;Acc:MGI:96231]
heat shock protein 1
[Source:MGI
Symbol;Acc:MGI:96240]
fibroblast growth factor 11
[Source:MGI
Symbol;Acc:MGI:109167]
regulatory factor X, 4
(influences HLA class II
expression) [Source:MGI
Symbol;Acc:MGI:1918387]
triggering receptor expressed
on myeloid cells 2
[Source:MGI
Symbol;Acc:MGI:1913150]
heat shock protein 1A
[Source:MGI
Symbol;Acc:MGI:96244]
heat shock protein 1-like
[Source:MGI
Symbol;Acc:MGI:96231]
aminolevulinic acid synthase
1 [Source:MGI
Symbol;Acc:MGI:87989]
heat shock protein 1B
[Source:MGI
Symbol;Acc:MGI:99517]
dynein, axonemal,
intermediate chain 1
[Source:MGI
Symbol;Acc:MGI:1916172]
heat shock protein 1
[Source:MGI
Symbol;Acc:MGI:96240]
eukaryotic translation
initiation factor 4E binding
protein 3 [Source:MGI
Symbol;Acc:MGI:1270847]
serum amyloid A 1
[Source:MGI
Symbol;Acc:MGI:98221]
gremlin 2 homolog, cysteine
knot superfamily (Xenopus
laevis) [Source:MGI
Symbol;Acc:MGI:1344367]
Purkinje cell protein 4-like 1
[Source:MGI

Ave.
FC
-2.69

Ave.
FDR
0.045

Tools

-2.43

0.027

-2.14

0.085

-2.06

0.062

2.21

0.049

2.22

0.004

DESeq2.
EdgeR

-3.54

0.002

DESeq2.
EdgeR

-3.36

0.001

DESeq2.
EdgeR

-3.25

0.011

DESeq2.
EdgeR

-3.14

0.004

DESeq2.
EdgeR

-2.94

0.059

DESeq2.
EdgeR

-2.63

0.022

DESeq2.
EdgeR

-2.45

0.006

DESeq2.
EdgeR

-2.44

0.047

DESeq2.
EdgeR

-2.37

0.047

DESeq2.
EdgeR

-2.19

0.000

DESeq2.
EdgeR

DESeq2.
EdgeR.
Aldex2
DESeq2.
EdgeR.
Aldex2
DESeq2.
EdgeR.
Aldex2
DESeq2.
EdgeR.
Aldex2
DESeq2.
EdgeR
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Tbc1d30
Cyp26b1

Fgf11
Ank3
Gdf15
Trem2

Gngt1

Vldlr
Rfx4

Raet1d
Pdk4

Adcy1
Ntrk2
Cyp2b9

Control

Impaired
fasting blood
glucose

ccl21c
Cyp26b1

Mfsd2a

Symbol;Acc:MGI:1913675]
TBC1 domain family,
member 30 [Source:MGI
Symbol;Acc:MGI:1921944]
cytochrome P450, family 26,
subfamily b, polypeptide 1
[Source:MGI
Symbol;Acc:MGI:2176159]
fibroblast growth factor 11
[Source:MGI
Symbol;Acc:MGI:109167]
ankyrin 3, epithelial
[Source:MGI
Symbol;Acc:MGI:88026]
growth differentiation factor
15 [Source:MGI
Symbol;Acc:MGI:1346047]
triggering receptor expressed
on myeloid cells 2
[Source:MGI
Symbol;Acc:MGI:1913150]
guanine nucleotide binding
protein (G protein), gamma
transducing activity
polypeptide 1 [Source:MGI
Symbol;Acc:MGI:109165]
very low density lipoprotein
receptor [Source:MGI
Symbol;Acc:MGI:98935]
regulatory factor X, 4
(influences HLA class II
expression) [Source:MGI
Symbol;Acc:MGI:1918387]
retinoic acid early transcript
delta [Source:MGI
Symbol;Acc:MGI:1861032]
pyruvate dehydrogenase
kinase, isoenzyme 4
[Source:MGI
Symbol;Acc:MGI:1351481]
adenylate cyclase 1
[Source:MGI
Symbol;Acc:MGI:99677]
neurotrophic tyrosine kinase,
receptor, type 2 [Source:MGI
Symbol;Acc:MGI:97384]
cytochrome P450, family 2,
subfamily b, polypeptide 9
[Source:MGI
Symbol;Acc:MGI:88600]
C-C motif chemokine 21c
[Source:UniProtKB/SwissProt;Acc:P86793]
cytochrome P450, family 26,
subfamily b, polypeptide 1
[Source:MGI
Symbol;Acc:MGI:2176159]
major facilitator superfamily
domain containing 2A
[Source:MGI
Symbol;Acc:MGI:1923824]

-2.09

0.001

DESeq2.
EdgeR

-2.07

0.056

DESeq2.
EdgeR

-2.04

0.089

DESeq2.
EdgeR

2.03

0.001

DESeq2.
EdgeR

2.03

0.065

DESeq2.
EdgeR

2.04

0.008

DESeq2.
EdgeR

2.06

0.062

DESeq2.
EdgeR

2.13

0.056

DESeq2.
EdgeR

2.20

0.012

DESeq2.
EdgeR

2.38

0.050

DESeq2.
EdgeR

2.65

0.001

DESeq2.
EdgeR

4.10

0.039

DESeq2.
EdgeR

4.90

0.000

DESeq2.
EdgeR

7.03

0.063

DESeq2.
EdgeR

-6.32

0.022

DESeq2.
EdgeR

-5.16

0.000

DESeq2.
EdgeR

-4.74

0.004

DESeq2.
EdgeR
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Cyp2b10

Serpina12

Adarb2
Epha5

Muscle

Tolerant
MNR
Control
Control

Intolerant
MNR
MNR
Intolerant
MNR

mt1
NA
Gdpd3

Il1f9
Cyp1b1

Control

Impaired
fasting blood
glucose

Nr4a3

Slc25a25

Irs2
Panx1

Adipose
tissue

Tolerant
MNR

Intolerant
MNR

Kcna6

Control

MNR

Napsa

Control

Intolerant
MNR

Cox8a
Zcchc24
Inpp5d
Vwa1

cytochrome P450, family 2,
subfamily b, polypeptide 10
[Source:MGI
Symbol;Acc:MGI:88598]
serine (or cysteine) peptidase
inhibitor, clade A (alpha-1
antiproteinase, antitrypsin),
member 12 [Source:MGI
Symbol;Acc:MGI:1915304]
adenosine deaminase, RNAspecific, B2 [Source:MGI
Symbol;Acc:MGI:2151118]
Eph receptor A5
[Source:MGI
Symbol;Acc:MGI:99654]
metallothionein 1

-2.93

0.001

DESeq2.
EdgeR

-2.19

0.015

DESeq2.
EdgeR

2.29

0.016

DESeq2.
EdgeR

2.62

0.065

DESeq2.
EdgeR

2.47

0.057

NA
glycerophosphodiester
phosphodiesterase domain
containing 3 [Source:MGI
Symbol;Acc:MGI:1915866]
interleukin 1 family, member
9 [Source:MGI
Symbol;Acc:MGI:2449929]
cytochrome P450, family 1,
subfamily b, polypeptide 1
[Source:MGI
Symbol;Acc:MGI:88590]
nuclear receptor subfamily 4,
group A, member 3
[Source:MGI
Symbol;Acc:MGI:1352457]
solute carrier family 25
(mitochondrial carrier,
phosphate carrier), member
25 [Source:MGI
Symbol;Acc:MGI:1915913]
insulin receptor substrate 2
[Source:MGI
Symbol;Acc:MGI:109334]
pannexin 1 [Source:MGI
Symbol;Acc:MGI:1860055]
potassium voltage-gated
channel, shaker-related,
subfamily, member 6
[Source:MGI
Symbol;Acc:MGI:96663]
napsin A aspartic peptidase
[Source:MGI
Symbol;Acc:MGI:109365]
cytochrome c oxidase,
subunit VIIIa [Source:MGI
Symbol;Acc:MGI:105959]
zinc finger, CCHC domain
containing 24 [Source:MGI
Symbol;Acc:MGI:1919168]
inositol polyphosphate-5phosphatase D [Source:MGI
Symbol;Acc:MGI:107357]
von Willebrand factor A

NA
-5.78

NA
0.071

DESeq2.
EdgeR
NA
DESeq2.
EdgeR

-3.59

0.013

DESeq2.
EdgeR

-2.34

0.028

DESeq2.
EdgeR

-4.54

0.050

DESeq2.
EdgeR

-2.81

0.040

DESeq2.
EdgeR

-2.80

0.025

DESeq2.
EdgeR

2.08

0.014

2.31

0.061

DESeq2.
EdgeR
DESeq2.
EdgeR

172.97

0.012

DESeq2.
EdgeR

2.30

0.038

DESeq2.
EdgeR

2.35

0.067

DESeq2.
EdgeR

2.70

0.032

DESeq2.
EdgeR

2.84

0.079

DESeq2.
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Timp4

Gcnt1

Xlr3b
Lrriq3
Napsa
NA

domain containing 1
[Source:MGI
Symbol;Acc:MGI:2179729]
tissue inhibitor of
metalloproteinase 4
[Source:MGI
Symbol;Acc:MGI:109125]
glucosaminyl (N-acetyl)
transferase 1, core 2
[Source:MGI
Symbol;Acc:MGI:95676]
X-linked lymphocyteregulated 3B
leucine-rich repeats and IQ
motif containing 3
napsin A aspartic peptidase
[Source:MGI
Symbol;Acc:MGI:109365]
NA

EdgeR
3.43

0.020

DESeq2.
EdgeR

3.56

0.052

DESeq2.
EdgeR

-2.09

0.019

-2.02

0.032

1.96

0.001

DESeq2.
EdgeR
DESeq2.
EdgeR
DESeq2.
EdgeR

NA

NA

NA

Note: Fold change (FC) and false discovery rate (FDR) are expressed as an average
between to the differential expression tools.
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